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Abstract 
 
 Methylmercury biosynthesis is a biologically-mediated process linked to expression of 
the recently discovered hgcAB gene products. The environmental conversion of toxic Hg(II) to 
MeHg, which exhibits even greater biological toxicity, is of concern to ecological food webs and 
piscivorous human populations. The mechanism by which HgcA and HgcB are responsible for 
Hg(II) methylation is unknown, but may represent a departure from canonical enzymatic 
methylation via carbocation mechanisms. The hgcAB genes are always found in genomic 
proximity to one another and predicted to interact within distances amenable to electron transfer 
in the proposed mechanism of Hg methylation. HgcA is a 40kDa protein comprised of cytosolic 
and transmembrane domains; the cytosolic domain is predicted to bind a cobalamin cofactor, 
based on its sequence homology to a known cobalamin-binding protein, which is suggested to 
serve as the catalytic center of the mercury methylation reaction. HgcB contains two [4Fe-4S] 
clusters and three additional conserved cysteine residues which we hypothesize are responsible 
for binding divalent mercury.  
 No in vitro study of HgcA or HgcB has yet been conducted to our knowledge, and this 
dissertation presents the first protocols for the heterologous expression of both HgcA and HgcB. 
HgcA contains a C-terminal transmembrane domain and both proteins contain metal cofactors 
which present significant barriers to heterologous production; thus, Escherichia coli cell lines 
containing co-expression plasmids for cofactor assembly were constructed to circumvent these 
challenges. In Chapter 2, the HgcB protein was expressed and purified as a maltose-binding 
protein fusion with 2 iron-replete [4Fe-4S] clusters, as determined by UV-visible and EPR 
spectroscopic techniques. A series of HgcB variants were constructed containing alanine or 
serine substitution of the cysteine residues hypothesized to comprise a mercury binding site. The 
mercury binding characteristics of these variants were probed using stopped-flow rapid kinetics 
and the results indicated agreement with the requirement for cysteine 73 and either cysteine 94 or 
95 observed in vivo. This study (a) indicates that these C-terminal cysteine residues are involved 
in the interaction of HgcB and mercury, and (b) establishes a production system to facilitate 
 xii 
further exploration of this role. It was found in Chapter 3 that truncated HgcA constructs lacking 
the C-terminal binding domain are not competent to bind cobalamin cofactor. The full-length 
HgcA protein was expressed in the presence of high intracellular cobalamin and preliminary UV-
visible characterization of the holo-FL-HgcA protein is presented. This expression and 
purification method comprises the critical first step toward in vitro validation of the functionality 
of HgcA as a mercury methylase, as well as the finding that the C-terminal transmembrane 
domain of HgcA is required for cofactor binding. These studies provide the first characterization 
of purified HgcA and HgcB, components of a biological system with the puzzling role of 
synthesizing highly toxic MeHg.  
 1 
Chapter 1 Introduction to Biological Methylation of Mercury 
 
1.1 Mercury and methylmercury in health and the environment 
 Mercury (Hg) is a trace metal which exhibits high biological toxicity1. It is estimated that 
one-third2 to two-thirds3 of yearly Hg inputs into the environment are anthropogenic in origin, 
primarily due to coal combustion and industrial process waste; other environmental deposition is 
geologic in origin. Elemental Hg(0) is liquid at room temperature, thus its environmental cycling 
is controlled by complex atmospheric equilibria at the air-water interface. Hg(0) is deposited into 
aquatic systems from the atmosphere, where it is subject to redox processes and 
methylation/demethylation equilibria as shown in Figure 1.14. Inorganic Hg(II) is highly toxic 
and causes acute kidney failure in vertebrates at low doses1, though its exact mechanisms of 
toxicity are poorly understood across kingdoms of life. It is thought that Hg biological trafficking 
and toxicity are the result of the high affinity of Hg(II) for thiolate coordination. 
Monomethylmercury (MeHg) is a neurotoxin and bioaccumulates within the aquatic food web, 
with high MeHg concentrations found in fish, bird, and mammal species at high trophic levels5; 
this occurs due to the propensity of MeHg to cross the blood-brain barrier. 
 
Figure 1.1 Schematic depiction of relevant equilibria in the Hg biogeochemical cycle. Hg(0) 
and Hg(II) deposition into the environment results in a complex global cycle across the 
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atmosphere-water interface. Hg(II) undergoes biologically-mediated methylation and 
demethylation at the sediment-water interface. Adapted from Reference 1. 
 
 Methylation of environmental Hg increases with increased atmospheric deposition6, and 
rising MeHg levels are a serious threat to fish-consuming human populations2. Processes such as 
permafrost thaw7, which is of immediate concern due to high levels of Hg accumulation in Arctic 
environments affected by global climate change, can also cause a rapid increase in an 
ecosystem’s Hg methylating activity. Curiously, neurotoxic MeHg is biosynthesized by 
microorganisms – that is, a biologically mediated process exists which converts toxic Hg(II) to 
the more toxic MeHg, neither of which are known to serve any advantageous biological function. 
Biological methylation of Hg was first proposed in 1969, after observing that, though the 
dominant Hg species in aquatic environments is inorganic Hg(II), MeHg is the species which 
accumulates in fish tissue8. Metabolic inhibitors against various classes of organisms identified 
sulfate-reducing bacteria (SRB) as the primary Hg methylators9 and radiocarbon labelling studies 
linked MeHg biosynthesis to serine and folate metabolisms and implicated the involvement of a 
methylcobalamin (MeCbl) cofactor10. Choi and Bartha conducted a series of studies investigating 
this link in the early 1990’s, indicating that generation of MeHg is likely enzyme-catalyzed 
rather than an abiotic reaction of free MeCbl11 and identifying a 40kDa corrinoid protein in a 
Desulfovibrio species as a putative methylase using a series of 57Co and 14C radolabelling 
studies12, but little additional information on the biochemical pathway by which bacterial Hg 
methylation proceeds was published until 2013. 
1.2 hgcAB-linked mercury methylation 
 Parks et.al.13 used a bioinformatics approach to search the genomes of known Hg 
methylators for a common, cobalamin-dependent methyltransferase, and identified the hgcAB 
genes as biomarkers of Hg methylation capability. At the time of this discovery, four species of 
SRB and two species of the genus Geobacter were known to methylate Hg in monoculture.  
Establishing a genetic link to the Hg-methylating phenotype led to the identification of an 
additional 46 Hg methylators across the kingdoms of Bacteria  and Archaea, and this number has 
since grown to over 200 species containing homologs of hgcAB14.  
 A phylogenetic analysis conducted in 2013 grouped the 70 hgcAB gene clusters found in 
available genomes into 5 clades: three among Deltaproteobacteria (including every species of 
Geobacter, save one), methanogens within Euryarchaeota, and Clostridia15. This work solidified  
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the link between Hg methylation capability and hgcAB by showing that hgcAB- close 
evolutionary relatives of a variety of hgcAB+ organisms cannot methylate Hg, whereas all tested 
hgcAB+ organisms do methylate Hg; this definitively showed that MeHg biosynthesis requires 
the hgcAB genes. The authors of this study emphasize that the vast diversity of newly identified 
Hg methylating organisms necessitates an expansion of Hg methylation study to previously 
unrecognized environmental niches, including those in which the dominant Hg methylators are 
methanogenic Archaea: these include rice paddies16, permafrost and Arctic sediments17, and 
freshwater aquatic systems18.  
 Methanogens have recently been shown to methylate Hg at similar rates to SRB and iron-
reducing bacteria when those rates are adjusted for total cell protein14, in contrast to older reports 
that these species were not significant contributors to environmental Hg production9. Syntrophic 
effects on Hg methylation are an area of exploration which have also benefited from the 
identification of the hgcAB biomarkers; synergistic growth between Hg-methylating SRB and 
methanogens was first observed in 199819, and a recent report has shown stimulation of MeHg 
production in environmentally relevant combinations of Hg-methylating organisms with 
syntrophic metabolic relationships20. One niche in which the hgcAB genes are conspicuously 
absent, as determined in a large-scale study of metagenomes17, is the vertebrate digestive 
microbiome – this suggests that human inorganic Hg exposure is not exacerbated by conversion 
to neurotoxic MeHg within the body. 
 Two nonexclusive hypotheses exist concerning evolutionary advantages which the hgcAB 
genes may provide. One is that these genes confer some resistance to Hg(II) toxicity; this does 
not appear to be the case in hgcAB+ organisms, based on cell growth rates in the presence or 
absence of Hg in Desulfovibrio desulfuricans ND132 and nearby genetic relatives21. This study, 
however, was conducted on a limited number of organisms before the identification of the hgcAB 
gene cluster and is not conclusive. It should be noted that methylmetals of arsenic, tin, and 
selenium are formed by microbial processes and thought to protect against the toxic effects of 
these elements by increasing their volatility and membrane permeability22–24, and this possibility 
cannot yet be eliminated for MeHg. The other conceivable function of HgcA and HgcB is that 
they catalyze some methyl transfer process associated with cellular carbon metabolism and 
methylate Hg(II) adventitiously as a side product. This is supported by two findings from global 
proteome studies: addition of Hg(II) to cultures of Desulfovibro desulfuricans ND132 did not 
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induce a change in the expression levels of HgcA and HgcB25, and a lower abundance of genes 
involved in the folate branch of the acetyl-CoA pathway was observed in a hgcAB deletion 
mutant of Geobacter sulfurreducens PCA26. At the time of this writing, no decisive work has 
been conducted to directly interrogate other metabolic functions of the hgcAB genes. In 
summary, study of HgcA and HgcB is just beginning and no conclusions can yet be drawn as to 
their biological role.  
 As HgcA is a cobalamin-dependent methyltransferase, this introductory chapter will 
review the known cobalamin-dependent abiotic and enzymatic methyl transfer processes. The 
putative roles of HgcB in both electron transfer through its iron-sulfur clusters and Hg binding 
via a cysteine-rich, high-affinity Hg(II) binding site will be also discussed. Finally, the proposed 
catalytic cycle for methyl transfer to Hg(II) and open questions will be presented as they relate to 
the scope of this dissertation research.  
1.3 Methylcobalamin and mechanisms of mercury methylation 
Cobalamin (Cbl), the structure of which is shown in Figure 1.2, is comprised of a cobalt 
atom coordinated by the 4 nitrogen atoms of the macrocyclic corrin ligand27. It is unique among 
tetrapyrroles in the addition of an intramolecular 5th ligand to the central cobalt which is 
covalently attached to the α-face of the macrocycle via a nucleotide linkage28. This axial base 
ligand is dimethybenzimidazole (DMB) in Cbl and not present in cobinamide (Cbi); the term 
“corrinoid” captures both of these compounds as well as those containing other base moieties. 
The Cbl cobalt center can access the +1, +2, and +3 oxidation states, and thus transfer alkyl 
cation, radical, and anion species29. In a 1974 review of toxic element cycles in the 
environment23, Wood discusses methylation of Hg(II) by methylcobalamin (MeCbl) as an early 
mechanistic hypothesis for MeHg biosynthesis, simply because of this capacity to transfer a 
methyl anion or radical. Reactions of other known biological methyl transfer donors, 
methyltetrahydrofolate (methyl-THF) and S-adenosylmethionine, result in transfer of a methyl 
cation; this species would be an unlikely ligand for Hg(II) on the basis of electrostatic repulsion.  
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Figure 1.2 Structure of the cobalamin cofactor  (a) Structure of the cobalamin cofactor, where 
X represents an upper axial ligand, such as X = CH3 in methylcobalamin (b) Representations of 
the coordination environments of cobalamin in the Co(III), Co(II), and Co(I) states, which 
assume coordination numbers of 6, 5, and 4, respectively. The planar face containing the Co 
atom represents the four-coordinate corrin ring, DMB is the base moiety coordinating the α-axial 
position, and X signifies the more readily exchangeable β-axial ligand.  
 
  When MeCbl was connected to MeHg production, it was unknown whether Cbl-
mediated Hg methylation was abiotic or enzyme-mediated. Abiotic methylation of Hg by MeCbl 
is thought to proceed via carbanion transfer to the electrophilic Hg(II), resulting in the products 
MeHg+ and cob(III)alamin30. This reaction has been shown to be faster for cobalamin vs. 
cobinamide, the latter lacking the dimethylbenzimidazole (DMB) moiety which coordinates the 
 6 
central Co atom, but also promoted by low pH, which increases the fraction of cobalamin in the 
“base-off” form due to protonation and weakened affinity of the DMB ligand31; this indicates 
both that DMB has a positive effect on the dealkylation of Cbl by Hg(II) but that its removability 
is also important in the reaction. Though this mechanism is not yet fully resolved, it has been 
observed that the abiotic reaction is slow at physiological pH and inhibited when Hg(II) is 
supplied as a bis-thiolate complex32. These findings are significant because intracellular 
methylation of Hg would presumably occur at near-neutral pH and Hg(II)-thiolate complexes are 
understood to be the dominant Hg species in cells and the environment33. Our knowledge of 
abiotic Hg methylation by Cbl is therefore consistent with the finding that environmental Hg 
methylation is, instead, enzymatically mediated by the corrinoid-dependent HgcA.  
1.4 HgcA and enzymatic corrinoid-dependent methyl transfer 
  Cbl enzyme cofactors catalyze an ever-increasing list of biological reactions34, including 
methyl group transfer. Well-characterized examples of this process include methionine synthase 
(MetH)35 and the corrinoid iron-sulfur protein (CFeSP)36, which is involved in the Wood-
Ljungdahl pathway of microbial acetogenesis. In both of these examples, the ability of the Cbl 
cofactor to access the Co(I) and Co(III) oxidation states is central to the mechanism of methyl 
transfer37. The “supernucleophilic” Co(I) state is capable of accepting a methyl group to form a 
Me-Co(III) corrinoid. This methyl group can then be transferred to homocysteine or the acetyl 
Co-A synthase nickel cluster, in the cases of MetH and CFeSP, respectively. These mechanisms 
result in the transfer of a methylcation (CH3
+), and the two electrons comprising the Co-C bond 
return to the Co to reset the catalytic cycle at the Co(I) state.  
 Four Cbl protein binding modes for which crystal structures are available are shown in 
Figure 1.3. Cofactor binding to these enzymes occurs in the “base-off” binding mode, in which 
the lower axial DMB moiety dissociates from the central Co atom and binds via contacts to a 
protein Rossmann fold.  In the case of MetH, th base is replaced by a protein His ligand35; 
CFeSP lacks a lower axial Cbl ligand, and instead binds via a “base-off” mode36. The recently 
characterized transcriptional regulator CarH similarly binds a cobalamin cofactor and provides 
two protein His ligands in a “base-off, bis-His” configuration reminiscent of common heme 
binding motifs38. Homology modelling based on sequence similary to the CFeSP suggests the 
cytosolic domain of HgcA, comprising ~18kDa of the 40kDa polypeptide, binds a corrinoid 
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cofactor in the “base-off, Cys-on” conformation through a Rossmann fold motif and coordination 
to the cobalt through Cys7313. A recent structural study has identified a “base-off, Cys-on” Cbl 
binding mode in a structure of a membrane associated corrinoid transport protein, BtuM39. This 
Cys residue, however, is suggested to catalyze decyanation of cyano-Cbl, and this enzyme does 
not appear to be involved in methyl transfer. Therefore, no system is known which provides an 
example of the effect of a lower axial Cys ligand on Co-C bond cleavage.  
 
Figure 1.3 Crystal structures of observed "base-off" cobalamin protein binding modes (a) 
“base-off, His-on” methionine synthase (MetH) (b) “base-off” corrinoid iron-sulfur protein 
(CFeSP) (c) “base-off, Cys-on” vitamin B12 membrane transporter (BtuM) (d) “base-off, bis-
His” light-dependent transcriptional regulator (CarH). The proteins are represented as colored 
cartoons while the cobalamin and relevant protein ligands are represented as sticks and colored 
by element. Rendered with Pymol from Protein Data Bank entries (a) 1BMT, (b) 4DJD, (c) 
6FFV, and (d) 58CF. 
 
 Cys73 is strictly conserved among hgcA genes, has been shown to be critical to Hg 
methylation in vivo40, and is hypothesized to have a dramatic effect on corrinoid-dependent 
methyl transfer via HgcA. Zhou et.al. constructed density functional theory calculations to model 
the trans effect of a thiolate ligand on Co-C bond cleavage41. They determined that a “base-off, 
Cys-on” Cbl coordination mode should modulate the bond dissociation energy of the Co-C bond 
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such that heterolysis releasing a carbanion (CH3
-) would be the energetically preferred mode of 
bond dissociation. Though the local protein environment could modulate this and experimental 
validation is necessary, this model provides a chemical rationale for the departure of HgcA from 
known mechanisms of enzymatic carbocation transfer and supports the mechanistic hypothesis 
first proposed in Parks et.al.13 (it should be noted that, though not observed in an enzymatic 
system, carbanion transfer is suggested in the abiotic methylation of Hg as discussed in section 
1.3, so this is not a corrinoid reaction without chemical precendent). In this mechanism, the 
HgcA corrinoid would first assume the Co(I) state to generate Me-Co(III) with an unknown 
methyl donor, then methyl transfer to the strongly electrophilic Hg(II) would result in a Co(III) 
corrinoid, with a requirement for reduction to Co(I) to reset catalysis. Essential to this process is 
the donation of two electrons every cycle to return the Co to the Co(I) state; this is the 
hypothesized role of HgcB.  
1.5 Mercury binding and HgcB, a [4Fe-4S] cluster ferredoxin-like protein 
HgcB is a 10kDa ferredoxin-like protein which contains two four-iron four-sulfur ([4Fe-
4S]) cluster CXXCXXCXXXCP consensus motifs. [4Fe-4S] clusters are an ancient and 
ubiquitious biological feature known to store and transfer low potential electrons42, and it is 
hypothesized that the HgcB iron-sulfur (Fe-S) clusters are responsible for 2-electron reduction of 
the Co(III) HgcA corrinoid after carbanion transfer. In the “base-off” CFeSP, the Co(II)/Co(I) 
midpoint redox potential is increased from the “base-on” potential of ~600mV to ~450mV43. We 
have no information on the Co(II)/Co(I) redox couple in HgcA, as this will be dependent on its 
coordination state, binding mode, and protein environment, but we anticipate that the HgcB 
clusters will exhibit sufficiently low midpoint potentials to reduce the corrinoid species. In 
addition to the 8 Cys residues involved in the Fe-S clusters, HgcB contains 3 strictly conserved 
Cys residues: Cys73, Cys94, and Cys95, with Cys94 and Cys95 occupying the C-terminus. 
Hg(II) has an strong preference for thiolate coordination, and it has been proposed that these Cys 
residues comprise a high-affinity Hg(II) binding site13. This could facilitate catalysis by 
positioning the Hg(II) in a favorable proximity for methylation. Peptide studies have shown that 
vicinal Cys residues are highly specific for Hg(II) binding over other thiophilic divalent metal 
ions, compared to CAAC and CACA motifs44. Cys-rich motifs, including those with vicinal Cys 
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pairs, have been observed and characterized in other Hg(II) binding proteins, notably those found 
within the mer operon.  
The mer operon encodes genes widespread in aerobic organisms which are responsible 
for uptake and degradation of MeHg45. This pathway involves Hg(II) dependent transcriptional 
activation by MerR, chaperoned import of Hg(II) or MeHg, cleavage of the Hg-C bond by the 
organomercurial lyase MerB, and reduction of the resulting Hg(II) to the relatively inert and 
nontoxic Hg(0) by MerA. All of these processes are mediated by Cys-based Hg(II) binding sites: 
MerT46 and MerF47, membrane Hg(II) transport proteins, contain Cys-Cys vicinal pairs, as do 
MerB48 and MerA49. A variety of Cys motifs are seen in other mer operon binding sites, 
including an unusual example in the MerR transcriptional regulator, which has been shown to 
bind Hg(II) with high affinity and specificity in a 3-Cys trigonal planar mode, in contrast to the 
typically preferred linear geometry50,51. An in vivo mutagenesis study of HgcA and HgcB in the 
model Hg methylator Desulfovibrio desulfuricans ND132 investigated the impact of alanine 
(Ala) substitution of the three conserved HgcB Cys residues40. These results indicated that Cys73 
and either Cys94 or Cys95 are required for in vivo Hg methylation activity, but the loss of one of 
the C-terminal pair can be accommodated. This suggests that some configuration of these 
residues is required for MeHg production, though in vitro characterization of these mutants 
would be required to confirm that the loss of Hg methylating activity is due specifically to Hg 
binding deficiency. 
1.6 Hypothesized mercury methylation process and scope of this dissertation 
 Figure 1.4 depicts the hypothesisized hgcAB-mediated MeHg biosynthesic scheme 
presented in Parks et.al. In this model, Co(III)-HgcA is reduced with two electrons transferred 
from the HgcB [4Fe-4S] clusters and methylated. The methyl-Co(III) corrinoid then transfers a 
methyl anion to a Hg(II) atom coordinated to HgcB via cysteine ligands, resulting in MeHg+ and 
a Co(III) species at the end of the catalytic cycle. This is a working model constructed using 
insight from homology modelling13, computational prediction41, and in vivo mutagenesis40 
studies. Though these have provided some insight into critical features of this process, as 
described in previous sections of this chapter, in vitro investigation is required to directly answer 
mechanistic questions. Is methylated HgcA capable of methyl transfer to Hg(II)? If so, what is 
the electronic nature of the methyl group which is transferred to Hg(II)? Does Cys73 coordinate 
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the HgcA corrinoid cofactor and affect Co-C bond dissociation? Is HgcB required for reduction 
of the corrinoid? Does it bind and supply the Hg(II) substrate to accelerate catalysis, as well? We 
suggest that these as-yet uninvestigated questions can be answered by biochemical and 
spectroscopic characterization of purified HgcA and HgcB. 
 
Figure 1.4 Working model of Hg methylation by HgcA and HgcB (1) Reduction of the HgcA 
corrinoid cofactor by 2-electron transfer from HgcB. It is unknown what electron donor may 
supply these low-potential electrons. (2) Methylation of Co(I)-HgcA by a methyl donor – this is 
written as methyltetrahydrofolate as many hgcAB+ organisms contain folate metabolic 
pathways, but it is unknown whether HgcA reacts directly with methyl-THF (3) Methyl transfer 
to Hg(II) to generate MeHg+ and the inactive Co(III)-HgcA. We hypothesize this Hg(II) is 
associated with HgcB. 
 
This thesis project was initiated to characterize the newly discovered HgcA and HgcB 
proteins from Desulfovibrio desulfuricans ND132. As no in vitro study of HgcA or HgcB has 
been conducted to date, any knowledge of their features gained in this work will be beneficial to 
further understanding of biological Hg methylation. Our particular interest in these proteins lies 
in their diverse metal centers, which are hypothesized to be critical to their novel functions. In 
Chapter II, UV-visible and electron paramagnetic resonance (EPR) spectroscopic 
characterization of HgcB was conducted to understand the composition of its predicted [4Fe-4S] 
cluster motifs. The Hg binding characteristics of a panel of HgcB Cys variants were probed using 
a Hg ligand-exchange titration coupled to stopped-flow rapid kinetics – this yielded insight into 
the in vivo functional requirement for Cys73 and either Cys94 or Cys95. In Chapter III, two 
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approaches were taken to HgcA production: generation of a truncated HgcA constructs to 
promote soluble heterologous expression and co-expression of the full-length transmembrane 
protein with a plasmid controlling cellular uptake of cobalamin. The latter technique resulted in 
the heterologous expression and purification of full-length HgcA, the UV-visible spectrum of 
which will be presented. These results provide the Hg biotransformation field with preliminary 
characteristics of these proteins, which will be valuable to further mechanistic understanding of 
MeHg biosynthesis.  
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Chapter 2 HgcB 
2.1 Introduction 
 Methylmercury (MeHg) is a neurotoxin synthesized by microorganisms containing the 
hgcAB genes1. Understanding the biosynthesis of MeHg is vital due to the risks posed to aquatic 
fish and bird species, as well as fish-consuming human populations, by environmental 
conversion of Hg(II) to MeHg2,3. Little is known about the biochemical mechanism by which 
this occurs, but it has been shown that deletion of either hgcA or hgcB eliminates the ability of 
Desulfovibrio desulfuricans ND132 and Geobacter sulfurreducens PCA to methylate mercury 
(Hg) in culture. These genes encode a 40kDa corrinoid-dependent methyltransferase with a C-
terminal transmembrane domain and a 10kDa ferredoxin-like protein with two four-iron four-
sulfur ([4Fe-4S]) consensus motifs, respectively. Based on similarity to characterized corrinoid-
dependent methyltransferase reactions, notably methionine synthase (MetH) and the corrinoid 
iron-sulfur protein (CFeSP)4, it is proposed that the HgcA corrinoid is reduced by HgcB to the 
Co(I) state, methylated by an as yet unidentified methyl donor, and the methyl group transferred 
to Hg(II), resulting in an inactive Co(III) state. HgcB has two proposed roles in this model: to 
supply low-potential electrons through its [4Fe-4S] clusters to reduce the HgcA corrinoid 
cofactor each catalytic cycle and to bind the Hg(II) substrate via its conserved cysteine (Cys) 
residues.  
 [4Fe-4S] clusters are ancient and ubiquitious cofactors known to store and transfer low 
potential electrons5. These are generally encoded by the consensus sequence 
CXXCXXCXXXCP and incorporate 4 atoms of divalent iron Fe and 4 equivalents of sulfide. 
The Fe atoms are coordinated by the Cys residues and bridged by sulfide ions, resulting in a 
cubane structure with an overall charge of +2 in the oxidized state. 1 electron reduction of this 
cofactor results in the delocalization of that electron within the cluster and a formal reduced 
charge of +1. Low-potential clusters have been observed with midpoint redox potentials ranging 
from -280mV to -705mV5. The Co(II) to Co(I) redox couple is low in the range of biological 
potentials, and reductions of MetH and CFeSP exhibit midpoint redox potentials of -526mV6 and 
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-504mV7, respectively. MetH is reduced by the higher potential flavodoxin protein, but the 
protein environment surrounding the corrinoid shifts the effective midpoint potential of the 
Co(II)/Co(I) couple by +50mV make the reduction by flavodoxin more favorable8. In the CFeSP, 
an internal [4Fe-4S] cluster is responsible for reduction of Co(II) and its 2+/1+ midpoint 
potential has been determined as -523mV. Thus it is hypothesized that the HgcB iron-sulfur 
clusters are sufficiently low in potential to reduce a similar corrinoid species.  
 Initial attempts by our collaborators at Oak Ridge National Laboratory to heterologously 
produce the hgcB gene from Desulfovibrio desulfuricans ND132 in Escherichia coli BL21 cells 
resulted in insoluble protein. Two approaches were combined to obtain soluble, iron-replete 
HgcB. The first was the cloning of a series of fusion protein constructs and testing their 
expression level and solubility after cell lysis. A maltose binding protein (MBP) tag was chosen 
for its high expression, solubility, and ease of purification via affinity resin. The second was the 
use of a co-expression plasmid shown to increase [4Fe-4S] cluster loading in overexpression 
systems9. The Ragsdale laboratory routinely uses co-expression systems in which cofactor 
uptake and/or assembly genes are encoded on a plasmid and co-transformed into the cell line 
expressing the protein of interest. The pRKISC plasmid was used in the expression of HgcB for 
characterization by UV-visible spectroscopy and EPR to assess its [4Fe-4S] motifs.  
 Another feature of interest in HgcB is its conserved Cys residues: Cys73, Cys94, and 
Cys95. Hg exhibits a high affinity for thiolate coordination and Hg binding proteins must 
compete with Hg complexation by intracellular thiolates. Peptide studies of Cys-Cys motifs have 
indicated both high affinity and specificity for Hg(II) over other thiophilic metals10. Several 
examples of vicinal Cys-Cys motifs are seen in the mer operon11, which encodes MeHg 
trafficking and detoxification genes and is highly specialized to bind Hg with high affinity. 
Though none of the relevant Cys residues are vicinal in sequence, an unusual 3-coordinate Cys-
Cys-Cys Hg(II) binding site is observed in the MerR transcriptional regulator12, which may also 
bear relevance to Hg binding by HgcB. In vivo mutagenic studies of Cys73, Cys94, and Cys95 
indicated the effect of alanine (Ala) substitution of these residues on in vivo Hg methylation 
activity in Desulfovibrio desulfuricans ND13213. These data are summarized in Table 1 and 
suggest that Cys73 and either Cys94 or Cys95 are required for MeHg production. 
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HgcB mutation % MeHg produced 
C73A None detected 
C94A 109% 
C95A 120% 
C94A/C95A 4% 
Table 2.1 Effect of Cys substitution with Ala at Cys 73, Cys94, and Cys95 on in vivo MeHg 
production in Desulfovibrio desulfuricans ND132. Percent values of MeHg produced are in 
comparison to the wild-type strain (adapted from Ref. 11). 
 
 
Figure 2.1 Schematic representation of the HgcB conserved cysteines. Cys94 and Cys95 are 
found on the C-terminus of the protein and thus likely to be exposed. The structural accessibility 
of Cys73 is unknown. 
 
We hypothesize that some configuration of the HgcB conserved Cys residues comprise a 
high-affinity Hg binding site. To test this hypothesis, we used stopped-flow kinetics to observe 
the dissociation of a colorimetric ligand, 2-nitro-5-thiobenzoate (TNB), from Hg(II) upon mixing 
with HgcB. Hg(TNB)2 is a high-affinity, stable complex, and only a high-affinity Hg binding site 
could rapidly induce its dissociation This mimics the proposed role of HgcB in binding 
intracellular Hg(II), which is typically coordinated to small molecule thiolates; we therefore view 
this experiment as a functional assay. We sought to test whether the same analysis of a variety of 
Cys73, Cys94, and Cys95 mutants would indicate deficiencies in their ability to bind Hg, 
suggesting which Cys residues are required for Hg binding.  
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2.2 Materials and Methods 
2.2.1 Materials 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
stated. All custom synthesized oligonucleotide primers were ordered from Integrated DNA 
Technologies (Coralville, Iowa). All restriction enzymes, the Q5 Site-directed mutagenesis kit, 
and amylose resin were purchased from New England Biolabs (Ipswich, MA). Pfu Ultra 
polymerase was used for all PCR reactions and obtained from Agilent (Santa Clara, CA). 
BL21(DE3) and TOP10 chemically competent cell lines were obtained from Invitrogen/Life 
Technologies (Carlsbad, CA). P2 resin was purchased from Bio-Rad (Hercules, CA). The codon-
optimized HgcB plasmid was custom synthesized by DNA2.0 and provided to us as a gift from 
Dr. Alexander Johs, Oak Ridge National Laboratory. cOmplete EDTA-free protease inhibitor 
tablets were acquired from Roche (Indianapolis, IN). Titanium (III) citrate was prepared 
similarly to the method of Zehnder and Wurhmann14 in 1M Tris-HCl pH 8.0. Maltose binding 
protein (MBP) was purified and provided by Dr. Eric Carter. 
2.2.2 HgcB fusion tag screen 
 Ligation independent cloning was used to generate a series of HgcB constructs with the 
N-terminal fusion protein tags GB115, MBP16, Mocr17, and SC-Mocr. The destination vectors are 
all derived from the pMCSG7 system and include an N-terminal His6 tag, the fusion protein tag, 
and a TEV proteolysis sequence upstream of the protein of interest18. Vectors were transformed 
into TOP10 cells and plated on LB agar selection plates containing 100ug/mL ampicillin. 
Sequences were verified by Sanger sequencing using the T7 terminator primer (University of 
Michigan DNA Sequencing Core) and transformed into BL21(DE3) cells. Cultures grown from 
single colonies were stored at -80°C in 25% glycerol and used to inoculate overnight starter 
cultures.  
 To test the expression of each of the four HgcB fusion constructs in BL21(DE3) cells, LB 
overnight cultures containing 100ug/mL ampicillin were inoculated from frozen cell stocks. 1mL 
of each overnight culture was used to inoculate 1L of LB media containing 100ug/mL ampicillin 
and incubated at 37°C with 225rpm shaking. Expression was induced by addition of 1mM IPTG 
between OD600 0.6-0.7. After 3 hours, the cells were harvested by centrifugation and frozen at -
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20°C. Whole-cell gel samples were taken before and after induction and analyzed by 
nonreducing SDS-PAGE on a 12% polyacrylamide gel.  
 Each cell pellet was resuspended in 10mL MOPS pH 7, 100mM NaCl, and 5mM DTT 
and sonicated at 4°C. 100uL of the lysis mixture was aliquoted into a microcentrifuge tube and 
centrifuged at 17,000xg in a tabletop microcentrifuge. The soluble lysate was removed and 
added to 100uL of 2X LDS sample loading buffer and 200uL 1X LDS buffer was used to 
resuspend the insoluble pellet fraction. These samples were analyzed by nonreducing SDS-
PAGE on a 12% polyacrylamide gel to determine the solubility of each construct after lysis.   
2.2.3 MHB co-expression with pRKISC and affinity purification 
 The protocol for overexpression of MBP-HgcB was modified from existing procedures 
for the heterologous expression of Fe-S proteins19,20. The vector containing His6-MBP-HgcB, 
abbreviated hereafter as MHB, was co-transformed into BL21(DE3) cells with the pRKISC 
vector and plated on LB agar selection plates containing 100ug/mL ampicillin and 5ug/mL (50% 
working concentration) tetracycline. A glycerol stock was prepared from a single resulting 
colony and used to inoculate LB overnight starter cultures. 20mL of an overnight culture 
containing LB medium, 100ug/mL ampicillin, and 10ug/mL tetracycline was used to inoculate 
1L of TB medium in a 1L bottle containing the same antibiotic concentrations. This was 
incubated at 37°C with 125rpm shaking until an OD600 ~0.6 was reached. At this point, each 
bottle was sealed with a septum and screw-cap ring and sparged with nitrogen gas for 1 hour. An 
additional 50ug/mL ampicillin and a reducing solution of 1mM sodium sulfide nonahydrate and 
1.5mM L-cysteine were added to each culture via syringe and incubated for 10 minutes. 0.5mM 
ferrous ammonium sulfate was added and 0.5mM IPTG was used to induce expression of the isc 
genes and MHB. Cultures were incubated overnight (18-20hrs) at 15°C with 125rpm shaking. 
Cells were harvested by centrifugation and stored at -20°C.  
 Cell lysis and amylose affinity purification were conducted under anoxic conditions (< 
1ppm oxygen) in a Vacuum Atmospheres anaerobic glove box. A cell pellet obtained from 4L of 
culture (~12g) was thawed in 50mL of lysis buffer containing 25mM Na HEPES pH 7.5, 5mM 
DTT, and 1 cOmplete EDTA-free protease inhibitor with gentle stirring. Cells were sonicated 
and the lysate cleared by centrifugation at 100,000xg. The soluble lysate was immediately 
applied to an amylose affinity column equilibrated with 5 column volumes (CV) of 25mM Na 
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HEPES pH 7.5 and 5mM DTT. 2.5CV of this buffer was used to wash the column and MHB was 
eluted with the same buffer containing 20mM maltose. The purified protein was analyzed for 
purity by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and the 
protein concentration determined by Bradford assay21. Purified MHB was stored in an anaerobic 
chamber at 4°C. 
2.2.4 Construction of MHB cysteine mutants by site-directed mutagenesis 
 C94A, C95A, and C94A/C95A mutants were constructed using the QuikChange II site-
directed mutagenesis protocol (Agilent) and transformed into TOP10 chemically competent 
cells. Successful transformants were chosen as single colonies from LB agar selection plates 
containing 100ug/mL ampicillin and verified by Sanger sequencing using the T7 terminator 
primer (University of Michigan DNA Sequencing Core). Cys73 mutants were constructed using 
the Q5 site-directed mutagenesis kit, transformed into NEB 5-alpha cells, and verified by Sanger 
sequencing as above. The MHB-CCC, MHB-CAC, MHB-CCA, or MHB-CAA vectors 
previously assembled were used as templates for the Cys73 mutagenesis reactions, resulting in 
the list of MHB variants below (Table 2). All expression of MHB Cys variants was conducted as 
described in section 2.2.3.  
Identifier Mutations 
MHB-CCC none 
MHB-CAC C94A 
MHB-CCA C95A 
MHB-CAA C94A/C95A 
MHB-SCC C73S 
MHB-SAC C73S, C94A 
MHB-SCA C73S, C95A 
MHB-SAA C73S, C94A, C95A 
Table 2.2 List MHB Cys variant identifiers used in this work 
2.2.5 UV-visible spectroscopy and reductive titrations of MHB 
 Purified MHB was exchanged into 20mM potassium phosphate (KPi) pH 7.4 using a 
30kDa MWCO centrifugal concentrator. The UV-visible spectrum was measured using an 
Agilent/HP 8453 UV-visible spectrophotometer in a quartz cuvette. A solution of the same 
buffer was used as a baseline spectrum. Sequential additions of titanium (III) citrate were used to 
generate a reduced MHB spectrum until the 390nm – 420nm region of the spectrum was no 
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longer quenched by further addition of reductant. The reduced spectrum was subtracted from the 
oxidized spectrum to generate a difference (Δ) spectrum, from which the [4Fe-4S] cluster 
concentration could be calculated using established molar extinction coefficients (Abs390 = 
4mM-1 iron and Δ415 = 8.2mM-1 for a protein containing two [4Fe-4S] clusters)22. All MHB 
variants were titrated with Ti citrate in the same manner.  
2.2.6 EPR spectroscopy of MHB 
 A MHB EPR sample was prepared by buffer exchange into 20mM KPi pH 7.4 and 
concentration to 250uM (500uM [4Fe-4S]). 10 equivalents (5mM) of titanium (III) citrate were 
added to the concentrated protein solution and allowed to incubate for 1 hour. Unreacted 
titanium (III) citrate was removed by buffer exchange in a centrifugal concentrator. The sample 
was transferred to an EPR tube and frozen in liquid nitrogen. X-band EPR data were collected at 
8.6K in a Bruker EMX spectrometer. The EPR instrument is equipped with a Bruker/ColdEdge 
helium cryostat and recirculation system and an Oxford Instruments Mercury iTC temperature 
and gas flow controller. 
2.2.6 Hg(TNB)2 complex preparation and MHB titration  
 The Hg(TNB)2 complex was prepared from DTNB and mercuric acetate according to 
published methods23 and purified by isocratic gel filtration into 50mM KPi pH 7.4 using a P2 
column. Fractions were assessed in the UV-visible range for the presence of a single peak at 
354nm and frozen at -20°C until use. Hg(TNB)2 concentration was determined using the 
extinction coefficient of 20.8mM-1 at 354nm. The MHB and MBP to be titrated with Hg(TNB)2 
were exchanged into 20mM KPi 7.4 by centrifugal ultrafiltration using a 30kDa MWCO. The 
protein samples were prepared in a Vacuum Atmospheres anaerobic glove box in quartz cuvettes 
and sealed with rubber stoppers. UV-visible measurements were conducted with a Shimadzu 
UV-2600 spectrophotometer outside of the anaerobic environment, and Hg(TNB)2 addition to 
the sample was made via gas-tight Hamilton syringe through the rubber septum.  
2.2.7 Stopped-flow kinetic studies of MHB variants and Hg(TNB)2  
 MHB samples for stopped flow experiments were prepared anaerobically by buffer 
exchange into 20mM KPi pH 7.4. The concentration of all protein samples were adjusted to 
25uM, as indicated by a 390nm absorbance of ~0.8. Hg(TNB)2 as prepared in section 2.2.6 was 
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diluted to 25uM in the same buffer. This buffer was also used to collect a baseline spectrum prior 
to stopped-flow data collection. Rapid kinetic analysis of the MHB-Hg binding interaction was 
conducted using an Applied Photophysics stopped-flow instrument housed in a Vacuum 
Atmospheres anaerobic glove box with an atmospheric oxygen concentration < 1ppm O2. All 
data were collected for 1 second at 20°C in photodiode array (PDA) mode using the 1cm path 
length configuration of the instrument. Stopped flow traces were collected in triplicate and fit to 
a double exponential model using ProData Viewer software. The deadtime of our instrument has 
been characterized as 1.8ms24, so data were fit from 2ms-1s. The MHB-SCC variant was the 
exception to this data treatment and could only be fit to a single exponential model. Standard 
deviations of triplicate observed rate constant values and amplitude values from the kinetic curve 
fits were calculated and plotted as error bars. 
2.3 Results and Analysis 
2.3.1 SDS-PAGE analysis of HgcB fusion tag screen 
 
Figure 2.2 SDS-PAGE analysis of HgcB fusion tag screen (a) Nonreducing SDS-PAGE 
analysis of whole-cell samples collected during test expressions of HgcB fusion constructs. Each 
set of samples is labelled by N-terminal tag and the left and right lanes represent samples 
collected immediately prior to IPTG induction and samples collected after 3 hour induction, 
respectively. (b) Nonreducing SDS-PAGE analysis of insoluble pellet and soluble lysate 
fractions after lysis of cells containing each of the four HgcB constructs. Samples are labelled as 
in (a) and lanes correspond to the pellet (P) and lysate (L) fractions, respectively.  
 
 Expression of HgcB variants after IPTG induction was indicated by the appearance of a 
gel band near the calculated MW of each fusion tagged construct. These are circled in red in 
Figure 2.2a and are not present in the pre-induction samples. After cell lysis, the distribution of 
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each construct in the insoluble (P) and soluble (L) fractions is shown in Figure 2.2b and 
indicated by arrows. From this it can be concluded that GB1-HgcB and Mocr-HgcB are not 
soluble after cell lysis under these conditions, and this gel is inconclusive in determining the 
fractionation of SC-Mocr-HgcB. MBP-HgcB is soluble after cell lysis, though some remains in 
the insoluble fraction. 
2.3.2 MHB expression and amylose affinity purification 
In a typical MHB preparation, ~2-3g of cells (wet weight) were obtained per L of culture. 
Due to iron precipitates observed in the harvested cells, a reliable final OD measurement could 
not be obtained. Brown colored fractions eluted from amylose affinity resin were collected and 
analyzed by SDS-PAGE. The gel revealed a band around the 50kDa molecular weight marker 
which we identify as MHB (54kDa) and a band below it around 45kDa (Figure 2.3, lane 2). This 
is consistent with the molecular weight of the MBP protein, and Western Blot analysis revealed 
that this band did bind an anti-MBP antibody (data not shown). A typical MHB preparation 
yielded approximately 25 mg of MHB as determined by Bradford assay. The MHB variants 
listed in Table 2.2 were expressed and purified as above with comparable cell density and 
purified protein yields.  In Figure 2.3, SDS-PAGE analysis of purified MHB variants showed 
that the purified Cys mutants also exhibit this double banding pattern by SDS-PAGE, though the 
relative intensities of the two bands varies between preparations. 
 
Figure 2.3 SDS-PAGE analysis of purified MHB variants. Amylose affinity column elution of 
each MHB variant. Lanes are labelled according to the Cys variant identifiers listed in Table 2.2. 
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2.3.3 UV-visible spectroscopy and reductive titration of MHB variants 
 Reduction of MHB and variants with titanium (III) citrate was monitored by observing 
the characteristic decrease in absorbance intensity in the 390nm-420nm region seen in many 
[4Fe-4S] proteins25, and is shown in Fig 2.4 below. Sequential additions of titanium (III) citrate 
were made until the 415nm absorbance reached a minimum; this required 3-4 equivalents 
titanium (III) citrate for all variants. A characteristic reductive titration of the MHB-CCC variant 
is shown in Figure 2.4. 
 
 
Figure 2.4 Titanium (III) citrate reduction of MHB-CCC. 25uM MHB-CCC was titrated with 
titanium (III) citrate by sequential additions of 25uM (1 equivalent). These data are 
representative of similar titrations of MHB variants with titanium (III) citrate. 
 
 As ferredoxins are typically small proteins, the ratio between the 280nm and 390nm 
absorbance can generally be used to determine the iron occupancy with good accuracy25. The 
280nm aborbance value of MHB, however, is saturated by contributions from the MBP fusion 
protein. The iron occupancy of [4Fe-4S] clusters can also be estimated by using the molar 
extinction coefficient at  of 4mM-1 Fe atoms at 390nm25; these values are calculated in the center 
columns of Table 2.3. If the value of Δ415nm is used to calculate protein concentration based on 
the value of ε(Δ415nm) = 8.2mM-1 for a protein containing two [4Fe-4S] clusters22, the MHB 
concentration values in the leftmost columns of Table 2.3 are in relatively good agreement with 
those determined from the 390nm absorbance. Cluster occupancy was calculated by comparing 
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the [MHB] derived from the Δ415nm absorbance values obtained after Ti citrate reduction to the 
protein concentration determined by Bradford assay. 
 
Table 2.3 UV-visible absorbance features of MHB variants and cluster occupancy 
calculation. Three methods of MHB concentration determination are shown from left to right: 
calculation of the concentration of titratable [4Fe-4S] cluster at 415nm, correlation of the 390nm 
absorbance value to Fe atom concentration, and comparison to a protein standard curve by 
Bradford assay.  
 
 The cluster occupancy values in Table 2.3 were surprising when associated with the SDS-
PAGE analysis in Figure 2.3. If the upper band of each gel lane corresponds to the fusion 
protein, it would be expected that approximately 25%-50% of the total protein concentration, as 
determined by Bradford assay, would correspond to MHB. In light of these results, we conclude 
either (a) the Bradford assay does not reliably represent the concentration of MHB or (b) the 
lower molecular weight gel band is also MHB, possibly a truncated product, and contains the 
MHB [4Fe-4S] clusters. For the purposes of concentration determination and consistency, the 
absorbance at 390nm was used to standardize the concentration of MHB across MHB variants in 
further experiments.  
 25 
2.3.4 MHB-CCC EPR spectrum 
 
Figure 2.5 EPR spectrum of MHB-CCC prepared by reduction with titanium (III) citrate 
Data collection parameters: 1mW power, 5G amplitude modulation, 4.5x103 gain, and 9.38 GHz 
frequency at 8.6K. 
 
 No EPR spectrum was detected in samples prepared by reduction with excess sodium 
dithionite (Em ~ -444mV vs. NHE); this may suggest that the MHB [4Fe-4S] clusters are quite 
low in potential and require a stronger chemical reductant, such as titanium (III) citrate (Em ~ -
550mV vs. NHE)26. The EPR spectrum of MHB-CCC was obtained after incubation with 10 
equivalents of titanium (III) and removal of excess reductant by buffer exchange. The spectrum 
collected at 8.6K can be seen in Figure and exhibits the characteristic feature of [4Fe-4S] clusters 
centered at g = 1.9427. Another signal centered at g = 2.0 is observed which bears resemblance to 
an organic radical species – this can be observed as an artifact of EPR cavity contamination and 
we hesitate to assign this feature to MHB. 
2.3.5 Hg(TNB)2 titration of MHB-CCC 
 Addition of Hg(II) species to iron-sulfur proteins is an established method for disruption 
of iron-sulfur clusters28 and inorganic Hg(II) exposure in Escherichia coli induces a rapid 
increase in intracellular labile iron, thought to occur due to disruption of protein-associated iron-
sulfur clusters29. As we are interested in testing the hypothesis that the 3 MHB conserved Cys 
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residues are involved in Hg(II) binding, we sought to minimize the potential for Hg to bind 
adventitiously to the 8 Cys residues involved in the [4Fe-4S] cluster motifs. 2-nitro-5-
thiobenzoate (TNB-), the disulfide of which is known as Ellman’s reagent30, forms a stable 
complex with Hg(II) and has been used by Ledwidge et.al. to supply Hg(II) to proteins 
containing high-affinity Hg binding sites23. As discussed in this work, the authors reasoned that 
both the TNB- ion and a protein Cys thiolate are high-affinity ligands for Hg(II), but the lower 
pKa of TNB should be more favored than anything other than coordination by an available Cys 
thiolate. We synthesized Hg(TNB)2 according to published methods and titrated it against MHB-
CCC. The Hg(TNB)2 complex exhibits a UV-visible maximum at 354nm, whereas the TNB 
anion peak is centered at 408nm. This provides for facile colorimetric observation of TNB anion 
release as an indirect measure of Hg(II) binding to the protein.  
 
Figure 2.6 Hg(TNB)2 titrations of 6uM MHB-CCC and 20uM MBP (a) Difference spectra 
obtained between sequential additions of 5uM increments of Hg(TNB)2 to 5uM MHB-CCC. (b) 
Wavelength maximum of the difference spectra obtained in a as a function of total Hg(TNB)2 
added. (c) Hg(TNB)2 addition to 20uM maltose binding protein.  
 
 We determined by this method that a large excess of Hg(TNB)2 dissociates upon addition 
of MHB-CCC (Figure 2.6a). The absorbance values at 408nm in the first three additions of 
Hg(TNB)2 (15uM total) correspond to a total concentration of TNB
- release of 30uM, consistent 
with 2 equivalents per Hg(II). Further additions of Hg(TNB)2 yielded a mixture of Hg(TNB)2 
and TNB- peaks, and the difference spectrum ceased reflecting Hg(TNB)2 dissociation after the 
addition of 6 equivalents of Hg(TNB)2 (Figure 2.6b). Purified MBP was titrated with Hg(TNB)2 
to exclude the possibility that this observation was an artifact of the MBP fusion tag (Figure 
2.6c). As expected, no dissociation of Hg(TNB)2 was observed upon addition to MBP, which 
does not contain any Cys residues. The free thiol concentration of MHB-CCC was determined by 
reaction with Ellman’s reagent as 12.7uM, which is consistent with the protein concentration of 
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5uM determined from the [4Fe-4S] cluster absorbance at 390nm. We suggest that the magnitude 
of TNB anion release presented here could be explained by the binding of Hg(II) to the MHB 
cluster Cys residues and concommittent disruption of the [4Fe-4S] clusters.  
2.3.6 Stopped-flow kinetic analysis of Hg binding to MHB variants 
 Stopped-flow rapid kinetic analysis was used to compare the Hg(TNB)2 dissociation rates 
and TNB- release rates of a panel of MHB Cys mutants to determine if differential rates were 
observed between the different MHB variants. We hypothesized that Hg(II) binding to an 
exposed Cys binding site would occur faster than iron-sulfur cluster displacement and these two 
processes could be identified using this technique. The MHB variants in which Cys residues 
required for Hg(II) binding are substituted with Ala or Ser would presumably only exhibit the 
comparatively slow displacement of the MHB [4Fe-4S] clusters. Data were collected for 1 
second upon mixing of 25uM Hg(TNB)2 and 25uM of each MHB variant. Figure 2.7a shows a 
representative stopped-flow data set in which the Hg(TNB)2 peak at 354nm disappears with the 
evolution of the TNB anion peak at 408nm and panel b overlays the absorbance values at these 
wavelengths over a 1 second time scale. These traces fit well to a double exponential kinetic 
model and these fits are overlaid with representative traces in Figure 2.7c. The exception to this 
data treatment is the MHB-SCC variant, in which the 408nm traces were better fit to a single 
exponential kinetic model (though the 354nm trace was still fit to a double exponential), shown 
in Figure 2.7d. 
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Figure 2.7 Representative stopped-flow absorbance data. (a) Overlay of spectra collected for 
1s upon mixing of 25uM Hg(TNB)2 to 25uM MHB-CCC. Arrows indicate the associated 
decrease in 354nm absorbance and increase at 408nm. (b) Absorbance vs. time traces at 354nm 
(bottom, pink) and 408nm (top, black). (c) Representative double exponential curve fits overlaid 
with the corresponding data at 354nm and 408nm. Residuals are plotted across the bottom in 
green. (d) Representative single exponential curve fits overlaid with the corresponding MHB-
SCC data at 354nm and 408nm. Residuals are plotted across the bottom in red. 
 
 To our surprise, all eight Cys variants induced rapid dissociation of the Hg(TNB)2 
complex. The observed rate constants and the corresponding absorbance amplitudes for each 
exponential phase are organized by wavelength, with 354nm analysis shown in Figure 2.8 and 
408nm analysis in Figure 2.9. Several striking observations can be made from comparisons 
between these MHB variants:  
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(1) The rapid dissociation of Hg(TNB)2 (Figure 2.8a), as indicated by the disappearance of 
the 354nm peak, displays rate constants of ~100s-1 in the CCC, CAC, CCA, and SCC 
variants. This rate is lowered by a factor of 2 in the remaining 4 variants. The trend 
observed here is a more rapid dissociation of Hg(TNB)2 in variants containing two of the 
three relevant Cys residues. We propose that this is consistent with a preferential binding 
to these residues.  
(2) The TNB- release observed in the 408nm traces of the MHB SCC variant was best fit to a 
single exponential model, in contrast to all other data sets (Figure 2.9). The 354nm 
double exponential fits for the SCC variant reveal that the absorbance change associated 
with the second observed rate constant phase is a small fraction of the total Δ354nm 
(approx. 5%, Figure 2.8b & d), indicating that the 354nm data is effectively monophasic 
as well. We conclude from this observation that the MHB-SCC variant displays the 
simplest Hg(II) binding model in this data set, in which Hg(TNB)2 dissociation occurs at 
same rate (~100s-1) of TNB- release, indicative of Hg(II) binding to MHB-SCC at a 1:1 
ratio and releasing both equivalents of TNB-. We are unsure why this phenomenon is not 
also observed in the wild-type CCC variant.  
(3) If some configuration of Cys73, Cys94, and/or Cys95 comprises a Hg(II) binding site, we 
would expect the MHB-SAA variant to be deficient in Hg(II) binding and attribute 
Hg(TNB)2 dissociation induced by mixing with the SAA variant to the adventitious 
binding of Hg(II) to the [4Fe-4S] cluster Cys residues. The SAA variant appears 
kinetically equivalent to the CAA variant in these experiments, and both induce 
Hg(TNB)2 dissociation at a two-fold slower rate compared to the CCC, CAC, CCA, and 
SCC variants containing 2 of the 3 relevant Cys residues (Figure 2.8a). This leads us to 
the conclusion that wild-type Hg(II) binding requires Cys94 and/or Cys95.  
(4) The total absorbance change at both wavelengths is equivalent between all variants, but 
the observed rate constants for the fast and slow phases are not consistent between the 
processes observed at 354nm and 408nm. For instance, almost all Hg(TNB)2 dissociation 
upon mixing with the MHB-CAA variant occurs primarily in the faster observed phase 
with a rate constant of 50s-1 (Figure 2.8a & b). 60% of the total TNB- anion release, 
occurs in the slower phase observed in the data collected at 408nm, corresponding to a 
rate constant of 40s-1(Figure 2.9c & d). When the concentrations of these species are 
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calculated from these absorbance changes using their molar extinction coefficients, there 
is good agreement between the 3uM Hg(TNB)2 consumed in this phase and 7uM TNB
- 
generated. We are unsure, however, of how to assign the more rapid generation of TNB- 
at a rate constant of 250s-1 associated with a smaller fraction of Hg(TNB)2 dissociation. 
 
Figure 2.8 Kinetic parameters of 354nm curve fits (a) and (c) show the observed rate 
constants for fast (kobs1) and slow (kobs2) exponential phases in the double exponential fit, 
respectively. (b) and (d) show the corresponding 354nm absorbance change (amplitude) 
represented by each phase. 
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Figure 2.9 Kinetic parameters of 408nm curve fits (a) and (c) show the observed rate 
constants for fast (kobs1) and slow (kobs2) exponential phases in the double exponential fit, 
respectively. (b) and (d) show the corresponding 408nm absorbance change (amplitude) 
represented by each phase. 
2.4 Discussion 
2.4.1 Purification of MHB and Cys variants generates an iron-replete [4Fe-4S] protein 
 MBP was found to have a positive effect on HgcB expression as a solubilizing affinity 
fusion tag and the resulting fusion protein, abbreviated MHB, was expressed with the pRKISC 
co-expression system resulting in the purification of iron-replete protein. Expression and 
purification of seven MHB variants yielded similar results. Figure 2.3 shows the presence of two 
bands in SDS-PAGE analysis of all MHB variants, the ratio of which varies between protein 
preparations. The higher molecular weight band is consistent with the weight of the MHB fusion 
protein (54kDa) and the lower is consistent with the weight of MBP (43kDa). Both bands were 
found to react with a polyclonal MBP antibody (data not shown) and we are unsure whether the 
lower band represents MBP not associated with HgcB or a truncated MHB product which retains 
the [4Fe-4S] clusters. This complicates the determination of protein concentration by Bradford 
assay, so concentrations are instead standardized to the UV-visible features of the [4Fe-4S] 
clusters.   
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 The UV-visible spectra of all MHB variants were similar and used to observe the 
reduction of the [4Fe-4S] clusters by titanium (III) citrate. It was found that sodium dithionite 
was unable to reduce MHB and 3-4 equivalents of Ti citrate were required to fully reduce both 
[4Fe-4S] clusters. The requirement for excess titanium (III) citrate, which has a reported 
midpoint redox potential of -550mV at pH 7, as well as the lack of complete reduction observed 
in the presence of dithionite may indicate that the average potential of the MHB [4Fe-4S] 
clusters may be quite low. The EPR spectrum of MHB-CCC is presented in Figure 2.5 and 
exhibits the characteristic S = ½ axial feature of [4Fe-4S] clusters centered at g = 1.9427. We are 
currently not assigning the g = 2.0 feature to the MHB protein and working to determine whether 
this signal is caused by organic radical contamination. Overall, MHB appears to exhibit standard 
characteristics of ferredoxin-like proteins containing 2 [4Fe-4S] motifs. 
2.4.2 Hg(TNB)2 addition to MHB results in superstoichiometric release of TNB- 
 A colorimetric Hg(TNB)2 complex was used to titrate MHB and probe its Hg(II) binding 
characteristics. This complex was used because the affinity of Hg(II) for TNB- complexation 
should only be bested by Cys thiolate coordination at neutral pH based on their relative pKa 
values23, so its colorimetric dissociation should indicate the stoichiometry of Hg(II) binding to 
MHB. This experiment indicated a release of TNB- far in excess of the protein concentration – 
this is not unsurprising considering that MHB contains 11 Cys residues and Hg(II) addition has 
long been used to disrupt iron-sulfur clusters28,31. These data, in the context of relative binding 
affinities between MHB mutants lacking different combinations of the Cys73/Cys94/Cys95 
residues implicated in in vivo functionality13, indicate that titration of a triple mutant lacking all 
three cysteines will still likely induce TNB- release, as it still contains 8 Cys residues involved in 
the [4Fe-4S] cluster motifs. This result presented a challenge to determination of the Hg(II) 
binding characteristics of MHB. Our goals were to (a) determine the Hg binding stoichiometry of 
HgcB and (b) identify the Cys residues required for retain that stoichiometry, but the indirect 
quantification of Hg(II) transfer by TNB- release proved too ambiguous to determine this. 
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2.4.3 Stopped-flow kinetic comparison between Hg(II) binding rates of MHB variants is 
consistent with observed in vivo requirements for conserved Cys residues 
 We then turned to stopped-flow experiments with the hypothesis that Hg(II) binding to 
the predicted Hg binding site would occur rapidly, whereas disruption of the protein [4Fe-4S] 
clusters would indicate a slower observed rate constant. We hypothesized that the Hg binding 
stoichiometry could be calculated from the amplitude of the predicted fast phase, and the 
eventual disruption of the [4Fe-4S] clusters could be deconvoluted from the Hg binding event, 
allowing side-by-side comparison of MHB variants with varying configurations of Cys residues. 
The stopped-flow data obtained by stoichiometric mixing of Hg(TNB)2 and 8 MHB Cys variants 
did not indicate such a straightforward assignation of kinetic phases.   
 Hg(II) has a strong preference for linear thiolate coordination environments, and its 
ligand exchange reactions have been shown to occur via transient 3-coordinate thiolate 
complexes rather than through initial dissociation of one of the two thiolate ligands32. We 
suggest this explains the observation that MHB variants containing at least two of the conserved 
Cys residues (CCC, CAC, CCA, and SCC) exhibit the fastest rates (~100s-1 in both the 354nm 
and 408nm fits) of Hg(TNB)2 decomposition, consistent with the rapid, sequential displacement 
of both TNB- ligands by MHB Cys residues. In the SCC variant, this was the only phase 
observed and the rate constant was equivalent to the observed rate of TNB- release, indicating a 
simple stoichiometric binding interaction. Vicinal CC motifs are known to select for Hg(II) with 
high affinity and preference over other thiophilic metal ions, so this is unsurprising10; the unusual 
result by comparison is that the observed rate constants for the CCC construct do not follow the 
same trends.  
 The CCC (wild-type) MHB construct displays two phases in its decay of Hg(TNB)2, of 
which the slower phase comprises ~60% of the total Δ354nm (Figure 2.8). Taken with the simple 
binding of Hg(II) to the SCC variant, this seems to indicate that Hg(II) binds quickly and rapidly 
to the C-terminal Cys residues, but some other process follows in the case of the CCC mutant. 
We are unsure what this process may be. The mercuric ion reductase, MerA, binds Hg(II) via a 
series of Cys residues to ultimately deliver it to the enzyme catalytic site for reduction by 
NADPH11. Intermediate steps in this process rely on the presence of an exogenous thiolate ligand 
to the Hg(II) to prevent the formation of an inactive complex between two nearby Cys residues33. 
 34 
It is possible that Cys73 is the ultimate destination of the Hg(II) ion but it is first bound by the C-
terminal Cys residues 94 and 95. The transfer of Hg(II) from Cys94/Cys95 to Cys73 could drive 
an equilibrium in which the Hg(II) is not stably bound to two Cys residues, such as is observed 
in the SCC variant, and eventually dissociates. This would explain both (1) the second phase 
observed in the CCC results compared to the SCC results and (2) the comparatively lower rates 
of Hg(TNB)2 dissociation by the CAA and SAA variants. The conserved Cys93 residue near the 
corrinoid active site in HgcA is an interesting feature to speculate on in this regard as well, as it 
may serve some role in Hg(II) transfer to the active site rather than as a ligand to the cofactor.  
 The CAA and SAA variants are kinetically equivalent in this experiment, with slow rates 
of Hg(TNB)2 dissociation, but comparatively high rates of TNB
- release in both observed phases. 
We interpret these data as indicative of adventitious Hg binding to the cluster Cys residues. 
Displacement of the cluster Fe atoms would be slower than binding to exposed C-terminal Cys 
residues, consistent with the slower observed rates of Hg(TNB)2 decay. A chain reaction could 
be envisioned, depending on the solvent accessibility of the clusters, in which several Hg atoms 
adventitiously exchange one TNB- ligand for a nonspecific protein Cys and lead to an eventual 
collapse of the [4Fe-4S] cluster and sudden availability of Cys residues for binding and release 
of any TNB- remaining associated with Hg(II). This model is speculative, but such a mechanism 
could be reconciled with the observed rapid rates for TNB- release observed in the CAA and 
SAA variants, as well as the elevated rates of TNB- release by the SAC and SCA variants.  
 Though the TNB- and Cys thiolates in this experiment are sufficiently low in formal 
redox potential to reduce the Hg(II) ion, we do not believe that this contributes to the observed 
reactions under these conditions for two reasons: (1) the association constants for thiolate 
coordination of Hg(II) make complexation far more favorable than electron transfer34, and (2) 
involvement of the TNB- in thiol/disulfide redox chemistry would be reflected in the UV-visible 
spectrum of this experiment. For example, a scenario in which one equivalent of TNB- is 
exchanged for one protein Cys residue, followed by reduction of Hg(II) and disulfide bond 
formation, would reflect only one equivalent of TNB- released per Hg(TNB)2, rather than the two 
equivalents observed in the Δ354nm and Δ408nm values. The low-potential [4Fe-4S] clusters 
seem more likely to be involved in Hg(II) reduction – this experiment, however, was conducted 
with as-purified oxidized clusters. No reductant is present in the system which could reduce the 
clusters for subsequent electron transfer to Hg(II), so this seems an unlikely explanation for the 
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kinetic traces observed. It has been proposed that a role for HgcB in electron transfer to Hg(II), 
rather than the HgcA corrinoid, could allow a carbocation mechanism to proceed in agreement 
with characterized cobalamin-dependent methylases, generating the observed MeHg+. The 
Co(III)-C bond, however, is highly stable and only activated for carbocation transfer by 
nucleophilic attack of a substrate such as homocysteine35 or the Ni-cluster of acetyl-CoA 
synthase36 – Hg(0) is an inert metal and thus unlikely to induce the same chemistry. 
2.4.4 Conclusions 
 This work has established a method for facile expression of HgcB as a MBP fusion 
protein in E. coli. UV-visible and EPR features of the purified protein are characteristic of [4Fe-
4S] ferredoxins and the cluster UV-visible absorbance features can be titrated by addition of the 
low-potential chemical reductant, titanium (III) citrate. The requirement for titanium (III) citrate 
reduction over that of sodium dithionite indicates that the HgcB [4Fe-4S] clusters likely exhibit 
low midpoint redox potentials, which agrees with their putative role in 2 electron reduction of a 
corrinoid species. The consistency between the CCC (wild-type) protein reductive titration and 
the MHB Cys variants indicates that site-directed mutagenesis of these Cys residues does not 
adversely affect the incorporation or stability of the [4Fe-4S] clusters.  
 A bis-2-nitro-5-thiobenzoate Hg(II) complex (Hg(TNB)2) was used as a colorimetric 
reporter of Hg(II) binding to MHB. Equilibrium titrations showed TNB- release in great excess 
of the available protein thiols hypothesized to bind Hg(II); we interpreted this result as indicative 
of adventitious Hg(II) binding to the Cys residues involved in the [4Fe-4S] motifs, thus Hg(II) 
binding stoichiometry could not be obtained. The observation of this reaction by stopped-flow 
rapid kinetics indicated rapid dissociation of Hg(TNB)2 even in the absence of all three 
conserved Cys residues – this was unexpected and likely can also be attributed to nonspecific 
binding of Hg(II) to the cluster Cys residues. It can be concluded, however, that MHB variants 
containing two of the three conserved Cys residues, Cys73/Cys94/Cys95, induced the fastest 
rates of Hg(TNB)2 dissociation, consistent with the Cys requirements for in vivo Hg methylation 
activity observed by in vivo mutagenesis experiments13. 
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Chapter 3 HgcA 
 
3.1 Introduction 
 As discussed in Chapter 1 of this work, corrinoid-dependent proteins catalyze a variety of 
reactions, including methyl transfer1. Their functions and reactivity are tuned by the protein 
environment around the cofactor and protein ligand coordation (or lack of). Corrinoid-dependent 
methyltransferases typically bind corrinoid cofactors in a “base-off” mode, in which the 
dimethylbenzimidazole (DMB), or base, moiety coordinating the alpha axial face of the central 
Co atom dissociates and binds within a protein Rossmann fold2. Methionine synthase (MetH) 
provides a His ligand to the cofactor3, but the corrinoid iron-sulfur protein (CFeSP) does not4. 
BtuM has been recently shown to coordinate one axial position with a Cys residue, the first 
example of such a coordination within a protein5. A light-dependent transcriptional regulator, 
CarH, binds in a “base-off, bis-His” motif, in which two His ligands coordinate both axial 
positions6. The crystal structures of these cobalamin binding modes are depicted  in Figure 2.1 
below. 
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Figure 3.1 Crystal structures of observed “base-off” cobalamin protein binding modes (a) 
“base-off, His-on” methionine synthase (MetH) (b) “base-off” corrinoid iron-sulfur protein 
(CFeSP) (c) “base-off, Cys-on” vitamin B12 membrane transporter (BtuM) (d) “base-off, bis-
His” light-dependent transcriptional regulator (CarH). The proteins are represented as cartoons 
while the cobalamin and relevant protein ligands are represented as sticks and colored by 
element. Rendered with Pymol from Protein Data Bank entries (a) 1BMT, (b) 4DJD, (c) 6FFV, 
and (d) 58CF. 
 
HgcA is a 40kDa corrinoid protein with a C-terminal transmembrane (TM) domain which 
has been implicated as the mercury methylase in methylmercury biosynthesis7. Based on 
sequence similarity to the CFeSP, homology modelling suggests that a Cys residue at position 93 
could coordinate to the “base-off” cofactor. We hypothesize this coordination would have a 
dramatic effect on the electronic environment and the mechanism of Co-C bond cleavage in the 
methylation reaction8, potentially rationalizing the proposed transfer mechanism in which a 
methyl anion, in a departure from characterized Cbl-dependent methyltransferases, is transferred 
to Hg(II)7. Cys93 has been shown to be critical to Hg methylation in Desulfovibrio desulfuricans 
ND132 in an in vivo site-directed mutagenesis study9. This work identified several other 
requirements for native functional competency of the hgcAB system, including the HgcA TM 
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domain – deletion of this region of the hgcA gene eliminated in vivo Hg methylation, indicating 
that it is required for MeHg biosynthesis in some capacity. Our current functional understanding 
of HgcA, therefore, lacks direct functional assignment of key features which could be supplied 
by in vitro study.  
HgcA is present at low levels in Desulfovibrio desulfuricans ND13210 and Geobacter 
sulfurreducens PCA11, thus it would be impractical to isolate quantities of protein required for in 
vitro characterization from these native sources. Heterologous expression of cobalamin-binding 
proteins, however, can present a significant technical challenge. Commonly used Escherichia 
coli derivative strains (BL21, C41, etc.) do not contain de novo corrinoid biosynthesis pathways, 
nor do they have a significant requirement for cobalamin under standard laboratory growth 
conditions12. Cobalamin uptake in Escherichia coli is tightly regulated by the binding of 
cobalamin to the mRNA encoding the cobalamin uptake gene, btuB, ensuring its transcription is 
not initiated when the cell’s need for cobalamin is met13. This presents a barrier to heterologous 
expression of enzymes which require corrinoid cofactors for folding, stability, and/or solubility, 
as this regulation ensures there is not sufficient intracellular cobalamin available for binding.  
In this work, two approaches were taken to heterologous production of cobalamin-replete 
HgcA. We first generated a panel of N- and C-terminally truncated variants of the HgcA soluble 
domain (lacking the predicted TM helices beginning approximately at position 175) and 
attempted cofactor reconstitution. Several variants were found to have enhanced solubility in 
comparison to HgcA-1-166, the construct purified as reported in Ref. 7, but none could be 
purified containing cobalamin or reconstituted with cofactor. The soluble truncated HgcA 
constructs exhibit UV-visible spectral shifts when added to Cbl, but cofactor reconstitution was 
assessed by electron paramagnetic resonance (EPR) spectroscopy to more definitively assess the 
Cbl coordination environment. “Base-on” cobalamin exhibits characteristic EPR spectral features 
arising from the interaction with the DMB nitrogen; the nuclear spin of the coordinating nitrogen 
atom causes superhyperfine splitting of EPR spectral features absent in the “base-off” 
configuration. EPR analysis of all constructs with which reconstitution was attempted indicated 
that the cofactor was still “base-on”.  
We reasoned that this inability to bind Cbl could arise from the removal of the TM 
domain. TM proteins present their own hurdles to heterologous overexpression, but advances in 
TM protein expression and extraction are constantly being made14–16 and we sought to test the 
 41 
hypothesis that the full-length (FL) protein is required to bind cofactor. In early 2018, a method 
for heterologous expression of cobalamin-binding proteins was published involving co-
expression with a plasmid copy of the endogenous E. coli btu operon17. This operon is 
responsible for cobalamin uptake and encodes the outer membrane transporter BtuB, periplasmic 
chaperone BtuF, as well as BtuC and BtuD which are responsible for inner membrane trafficking 
into the cytosol. The TonB-dependent cobalamin transporter, btuB, has been show to contain a 
premature stop codon in BL21-derived laboratory research strains18, rendering it dysfunctional, 
so the endogenous btu machinery cannot easily be exploited for the purposes of increases cellular 
Cbl uptake. By utilizing an inducible copy of the btu operon, we reasoned that an increase in the 
intracellular cobalamin pool could increase the likelihood of holo-FL-HgcA expression. Both 
FL-HgcA and HgcA-1-175 were co-expressed and purified from C41(DE3) cells in the presence 
of membrane-solubilizing detergents. The full-length and truncated proteins purified were 
characterized by SDS-PAGE analysis and UV-visible spectroscopy was used to compare the 
preliminary electronic features of the holo protein to known corrinoid proteins.    
3.2 Materials and Methods 
3.2.1 Materials 
 All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
stated. All custom synthesized oligonucleotide primers were ordered from Integrated DNA 
Technologies (Coralville, Iowa). The FL-HgcA gene was custom synthesized into a pJ411 vector 
by DNA2.0 (Newark, CA). Pfu Ultra polymerase was purchased from Agilent (Santa Clara, CA). 
All restriction enzymes, T4 DNA ligase, and amylose affinity resin were procured from New 
England Biolabs (Ipswich, MA). TOP10 and BL21(DE3) chemically competent cells were 
purchased from Invitrogen/Life Technologies (Carlsbad, CA), and C41(DE3) chemically 
competent cells were purchased from Lucigen (Middleton, WI). cOmplete EDTA-free protease 
inhibitor tablets were acquired from Roche (Indianapolis, IN). The pET-Duet-1 vector was 
purchased from Novagen (Madison, WI) and the pBAD42-BtuCEDFB plasmid was a gift from 
the laboratory of Prof. Squire Booker, Pennsylvania State University. Ni-NTA resin and all DNA 
purification kits used between cloning steps (QIAquick gel extraction kit, QIAprep spin miniprep 
kit, QIAquick PCR purification kit) are from Qiagen (Valencia, CA). 
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3.2.2 HgcA 1-166: EPR spectroscopy 
 HgcA-1-166 samples for EPR spectroscopic analysis were prepared and supplied by Dr. 
Stephen Tomanicek and Dr. Alexander Johs (Oak Ridge National Laboratory). The protein was 
purified as described in Ref. 7, added to a stoichiometric amount of aquacobalamin, and 
exchanged into 25mM Na HEPES pH 7.5 at a concentration of 90uM. Reduction of Cbl was 
performed by the addition of 4 equivalents of sodium ascorbate to generate the Co(II) oxidation 
state. Two Cbl control samples were prepared by the same method: a “base-on” and a “base-off” 
sample, the latter of which contained 0.1M HCl.  
 Maltose binding protein (MBP) fusion constructs of HgcA-1-166 were also prepared and 
analyzed by EPR. In addition to the wild-type 1-166 sequence, a construct was generated in 
which two non-conserved Cys residues found in the HgcA sequence at positions 47 and 142 
(SCS) were substituted with serine. These samples were prepared in the same buffer system as 
above, but Cbl reconstitution was carried out by addition of stoichiometric methylcobalamin 
(MeCbl). MeCbl was photolyzed by exposure to ambient light to generate the Co(II) oxidation 
state and a control MeCbl sample was prepared by the same method. These samples were found 
to be oxidized after shipping and reduced with two equivalents of titanium (III) citrate. 
3.2.3 HgcA truncated constructs: design and ligation-independent cloning of HgcA variants 
 
Figure 3.2 Start and end positions of HgcA truncated constructs. Bolded residues (Pro43 and 
Ala166) indicate the start and end positions of HgcA homology to CFeSP. 
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HgcA constructs were amplified from a commercially custom-synthesized pJ411 plasmid 
containing the FL-HgcA gene from Desulfovibrio desulfuricans ND132. This construct was 
codon-optimized for expression in Escherichia coli. Ligation-independent cloning (LIC) 
procedures were used to amplify HgcA variants with different combinations start and end 
positions and insert these constructs into the pMCSG7 vector and a modified pMCSG9 vectors19. 
These vectors contain N-terminal sequences encoding His6 and His6-MBP tags, respectively. 
Site-directed mutagenesis according to the Agilent QuikChange Site Directed Mutagenesis 
protocol was used to remove the His6 tag from pMCSG9 prior to its assembly with the HgcA 
constructs, with the resulting vector designated pMCSG9-NH. Sequences were verified by 
Sanger sequencing using the T7 terminator primer (University of Michigan DNA Sequencing 
Core). 
3.2.4 HgcA truncated constructs: expression/solubility tests and purification 
 His6-HgcA constructs contained in the pMCSG7 vector were transformed into 
BL21(DE3) cells. 50mL cultures containing LB medium and 100ug/mL ampicillin were 
inoculated from glycerol stocks and grown at 37ºC with 225rpm shaking. HgcA expression was 
induced for 3 hours at 37ºC with 1mM IPTG at OD600 ~0.7. Gel samples were prepared from 
these cultures before and 3 hours after induction by resuspending a cell pellet prepared by 
centrifugation (5 min, 5,000xg) in 100uL 1X LDS loading buffer. These gel samples were 
analyzed by SDS-PAGE using 12.5% polyacrylamide gels. The cultures were harvested by 
centrifugation at 5,000xg for 15 minutes and stored at -20ºC. To test solubility after cell lysis, 
each frozen cell pellet was resuspended in 5mL lysis buffer (50mM Tris pH 7.8, 100mM NaCl, 
5mM DTT, 1 Complete EDTA-free protease tablet per 50mL) and sonicated at 4ºC. A 100uL 
aliquot of each lysate was centrifuged in a benchtop microcentrifuge at 17,000xg for 10 minutes, 
and samples of the soluble and insoluble fractions were prepared for SDS-PAGE analysis. 
MBP-HgcA constructs 39-166, 43-166, and 33-175 were expressed as above in 1L 
cultures, but induction was carried out overnight (18 hours) at 15ºC. These cell pellets were 
harvested and frozen at -20ºC prior to lysis and purification. Cell lysis and amylose affinity 
purification were conducted under anoxic conditions (< 1ppm oxygen) in a Vacuum 
Atmospheres anaerobic glove box. Pellets were thawed in 50mL lysis buffer containing 50mM 
Na HEPES pH 7.5, 100mM NaCl, 5mM DTT, and 1 protease inhibitor tablet. The resuspended 
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cells were lysed by sonication at 4ºC and the lysate cleared by centrifugation at 100,000xg. The 
soluble lysate was immediately applied to an amylose affinity column equilibrated with 5 
column volumes (CV) of 25mM Na HEPES pH 7.5 and 5mM DTT. 2.5CV of this buffer was 
used to wash the column and MHB was eluted with the same buffer containing 20mM maltose. 
The purified protein was analyzed for homogenaity by SDS-PAGE. 
3.2.5 HgcA truncated constructs: cobalamin reconstitution analysis by UV-visible 
spectroscopy 
 All sample handling and data collection was conducted inside an anaerobic glove box. 
Purified MBP-HgcA constructs were exchanged into 50mM Na HEPES pH 7.5 in centrifugal 
concentrators with a 30kDa molecular weight cut off (MWCO) membrane for cofactor addition. 
Aquacobalamin was added to purified MBP-HgcA constructs at a 0.9:1 ratio, to ensure spectral 
shifts observed did not arise from unbound cofactor. Protein concentrations for this purpose were 
determined by Bradford assay20. UV-visible spectra were collected using an Agilent/HP 8453 
UV-visible spectrophotometer. 
3.2.6 FL-HgcA: restriction digest cloning into pET-Duet-1 
The FL-HgcA coding region and a truncated HgcA-1-175 construct were amplified by 
the polymerase chain reaction (PCR) from a custom synthesized, codon-optimized FL-HgcA 
vector (pFL-HgcA) with overhangs containing the BamHI and HindIII restriction enzyme sites. 
The PCR products and pET-Duet-1 vector were digested with both restriction enzymes, mixed 
and ligated using T4 DNA ligase, and transformed into TOP10 cells, generating the Duet-FL-
HgcA and Duet-HgcA-1-175 vectors. Sequences were verified by Sanger sequencing (University 
of Michigan DNA Sequencing Core). Each HgcA plasmid was co-transformed into C41(DE3) 
cells with pBAD42-BtuCEDFB and plated on LB agar selection plates containing 100ug/mL 
ampicillin and 25ug/mL spectinomycin (50% working concentration).  
3.2.7 FL-HgcA: co-expression with pBAD42-btuCEDFB and Ni-NTA affinity purification  
 Overnight starter cultures of C41(DE3) co-expression strains containing pBAD42- 
btuCEDFB and either Duet-FL-HgcA (pFL/pBtu) or Duet-HgcA-1-175 (p175/pBtu) were 
inoculated from single colonies in LB medium with 100ug/mL ampicillin and 50ug/mL 
spectinomycin. 100mL of the M9-ethanolamine media recipe described in Blaszczyk et.al.20 was 
 45 
prepared and inoculated with 0.75mL of the LB starter culture. HgcA expression was induced at 
OD600 ~0.7 overnight (16-18 hours) at 20ºC with 0.1 mM IPTG. Cells were harvested by 
centrifugation at 5,000xg and frozen at -20ºC. All purification steps were conducted in a cold 
room at 4ºC. Cell pellets were resuspended in 5mL lysis buffer containing 50mM KPi pH 7.4, 
100mM sodium chloride, 10% glycerol, cOmplete EDTA-free protease inhibitor, 2mM β-
mercaptoethanol (BME). The lysis buffer for the FL-HgcA strain also contained 1% N-lauryl 
sarcosine. Cells were lysed by sonication and centrifuged at 10,000xg for 30 minutes. 10mM 
imidazole was added to each soluble fractions and 2% Triton X-100 was added only to the FL-
HgcA preparation. Each lysate was applied to Ni-NTA resin equilibrated in 50mM KPi pH 7.4, 
100mM NaCl, 10% glycerol, 2mM BME and incubated with gentle shaking for 30 minutes. Each 
batch of resin was poured into a column and washed with 5CV of the equilibration buffer, and 
250mM imidazole was included with 2CV of the same buffer to elute protein bound to the 
column. Protein eluted from each column was assessed by UV-visible spectroscopy to determine 
if it was purified with bound cofactor. 
3.2.8 FL-HgcA: sample preparation for analysis by UV-visible spectroscopy 
FL-HgcA for UV-visible and EPR analyses was purified as in section 3.2.7 with the 
following exceptions: 3L of cells expressing pFL/pBtu were grown and lysed in 75mL lysis 
buffer, and 4mM imidazole, rather than 10mM imidazole, was added to the soluble lysate. The 
column elution was concentrated in a centrifugal concentrator with a 10kDa MWCO. The 
concentrated FL-HgcA was exchanged three times with the same buffer used for Ni-NTA 
column equilibration in section 3.2.7. The flow through the centrifugal concentrator was pink in 
color and analyzed by UV-visible spectroscopy along with the concentrated protein. UV-visible 
spectra were collected with a Shimadzu UV-2600 spectrophometer.  
3.3 Results and Analysis 
3.3.1 HgcA-1-166 constructs: EPR spectra 
 The EPR spectrum of HgcA-1-166 in Figure 3.3a closely resembles that of “base-on” Cbl 
(Figure 3.3b), with g values ~2.0 and ~2.3. Hyperfine splitting constants for cobalt and nitrogen 
in both of these species were calculated as ACo = 110G and AN = 18G. The acidified “base-off” 
Cbl sample (Figure 3.3c), in which protonation and dissociation of the DMB lower axial ligand 
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is promoted, exhibits no nitrogen superhyperfine splitting lines and a broadened ACo = 155G, 
typical of “base-off” corrinoid species4,22. Thus it was concluded that cobalamin addition to 
HgcA-1-166 does not yield a “base-off” reconstituted protein. EPR spectra of the MBP-HgcA 
variants in Figure 3.3d-e exhibit virtually identical features to the “base-on” spectra in Figure 
3.3a and f.  
 
Figure 3.3 EPR spectra of HgcA-1-166  constructs compared to "base-on" and "base-off" 
cobalamin. All EPR data collection parameters: 20mW power, 10G amplitude modulation, 
7x104 gain, and 9.28 GHz frequency at 100K. (a) HgcA-1-166 (b) cob(II)alamin (c) 
cob(II)alamin in 0.1M HCl. Samples a-c were prepared as described in Section 3.2.2 by 
reduction with sodium ascorbate. (d)  MBP-HgcA-1-166 (e) MBP-HgcA-1-166 SCS, in which 
two nonconserved Cys residues are mutated to serine (f) cob(II)alamin. A cob(II)alamin 
spectrum appears in each set of samples as a control comparison (a and f).  
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3.3.2 HgcA truncated constructs: SDS-PAGE analysis of construct expression and 
solubility 
 
Figure 3.4 HgcA truncated construct expression test analysis by SDS-PAGE. Lanes with 
numbered bands contain molecular weight standards. Constructs are labelled as pairs of gel lanes 
where the left lane corresponds to a pre-induction gel sample and the right lane corresponds to a 
post-induction gel sample of equivalent cell density. 
 
 The molecular weights of the HgcA truncated constructs range from 13.8kDa – 17.7kDa. 
The SDS-PAGE analysis in Figure 3.4 indicates the presence of band of appropriate molecular 
weight band in each of the 7 test expressions, marked by a white arrow, with the exception of 33-
162, which was inconclusive. These constructs include N-terminal His tags but no fusion tag to 
promote solubility, so their solubility after lysis was assessed in Figure 3.5. The same cells were 
lysed and their corresponding soluble and insoluble fractions were analyzed by SDS-PAGE in 
Figure 3.5.  
 
Figure 3.5 SDS-PAGE analysis of HgcA truncated construct solubility after cell lysis. “P” 
and “L” lanes designated for each construct correspond to the insoluble pellet and soluble cell 
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extract, respectively. White stars to the right of a gel band indicate a band of the appropriate 
molecular weight in the soluble lysate fraction.  
 
 HgcA-39-166, HgcA-43-166, and HgcA-33-175 were chosen for expression purification 
as MBP fusion constructs on the basis of the results in Figure 3.5. Figure 3.6 shows samples 
taken throughout the lysis and amylose affinity purification of MBP-HgcA-43-166 and is 
representative of all purifications of these constructs. The protein eluted from the amylose 
affinity column can be seen in the rightmost gel lanes (Fractions 1-3). The amylose affinity 
eluate contains minor contaminating bands, but appears mostly pure and was used for subsequent 
cofactor addition experiments.  
 
Figure 3.6 MBP-HgcA-43-166 amylose affinity purification analysis by SDS-PAGE. The 
numbered lane contains molecular weight standards. P and L represent the soluble and insoluble 
fractions of the cell lysate. The lane labelled “flow-through” contains the column flow collected 
as the soluble lysate was loaded on an amylose affinity column, and fractions 1-3 are the 
amylose column eluate. 
3.3.3 HgcA truncated constructs: UV-visible spectral analysis of cobalamin reconstitution 
 Substoichiometric (0.9:1) addition of to the purified MBP-HgcA variants yielded changes 
to the UV-visible spectrum. The 43-166 and 33-175 variants exhibit a feature at 475nm, which 
typically identifies “base-on” cob(II)alamin23. The 500nm region is red-shifted in the 39-166 
construct with a peak at 530nm; this feature is generally seen in glutathionylcobalamin, in which 
a thiolate ligand coordinates the β-axial position of “base-on” Cbl24. A spectrum of 
cob(III)alamin is provided as a reference for the species added to the proteins. These data are 
consistent with either (a) reduction of the cobalamin, likely by reduced surface Cys residues of 
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HgcA, in the cases of 43-166 and 33-175 or (b) the association of “base-on” Cbl with a protein 
Cys residue via β-axial coordination. There is no indication in these spectral changes of a “base-
off” reconstituted HgcA. 
 
Figure 3.7 UV-visible spectra of HgcA MBP fusion constructs upon stoichiometric addition 
of aquacobalamin 
3.3.4 FL-HgcA: Analysis of pBAD42-BtuCEDFB co-expression and affinity purification vs. 
HgcA-1-175 
 SDS-PAGE analysis of the Duet-FL-HgcA and Duet-HgcA-1-175 purification steps did 
not identify distinct bands of corresponding molecular weights (~40kDa and ~20kDa, 
respectively) to definitively assign to the two HgcA constructs (data not shown). The same 
analysis of the larger scale Duet-FL-HgcA expression (Figure 3.8) appears to indicate 
enrichment of an approximately 40kDa species, consistent with the molecular weight of FL-
HgcA. 
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Figure 3.8 SDS-PAGE analysis of FL-HgcA co-expressed with pBAD-BtuCEDFB. (1) 
soluble cell extract after lysis and centrifugation (2) Ni-NTA column flow-through during 
application of lysate (3) Ni-NTA column wash (4) Ni-NTA column elution. The ~40kDa band in 
Lane 4 is thought to correspond to FL-HgcA and is marked with a white arrow. pBAD42-
BtuCEDFB is abbreviated ‘pBtu’ for brevity.  
 
 The UV-visible spectra of FL-HgcA and HgcA-1-175 co-expressed with the pBAD42-
BtuCEDFB plasmid and purified aerobically by Ni-NTA affinity chromatography are presented 
below in Figure 3.9. The UV-visible spectrum of HgcA-1-175 exhibits a peak at 358nm with 
shoulders around 402nm and 535nm. This spectrum is not distinctive, but could be consistent 
with aquacobalamin, which has a dominant transition at 360nm and a feature composed of two 
overlapping peaks at 515nm and 545nm25. A spectrum with peaks at 358nm, 414nm, and a 
broader feature which appears to contain peaks at ~538nm and ~562nm is seen in the peach-
colored FL-HgcA elution. This is an unusual cobalamin spectrum – cob(III)alamin compounds 
generally exhibit a feature in the mid-300nm range and a broader set of transitions in the 500-
550nm range, with molar extinction coefficients 2.5-3 times higher in the higher energy peaks26. 
The ~1:1 ratio between the 358nm peak and 412nm peak is not typical, as there are generally no 
major electronic transitions in the 400nm region at all, and cannot be assigned to a well-
characterized cobalamin coordination environment.  
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Figure 3.9 UV-visible spectra of Ni-NTA purified HgcA variants co-expressed with pBAD-
BtuCEDFB. The FL-HgcA spectrum indicates maxima at 358nm and 414nm and a broad feature 
~538nm and ~562nm. The HgcA-1-175 spectrum is not very distinct and displays a major peak 
at 358nm.   
3.3.5 FL-HgcA: UV-visible spectrum  
 The FL-HgcA Ni-NTA column elution was concentrated in a centrifugal ultrafiltration 
device with a 10kDa MWCO membrane. The flow through the concentrator membrane was pink 
in color and its UV-visible spectrum is presented in Figure 3.10. This spectrum has well defined 
features with a maximum at 358nm which is ~3-fold higher in intensity than a shoulder around 
540nm. This closely resembles published spectra of aquacobalamin25,26, and likely represents 
cofactor nonspecifically associated with the purified FL-HgcA. The FL-HgcA spectrum, on the 
other hand, is characterized by a single broad feature with a maximum at 410nm and shoulder 
~427nm, with some indication of the lower intensity Co(III) 500-550nm transitions. Reduction 
of both Cbl and cobinamide (Cbi), which lacks the lower axial DMB moiety, from Co(III) to 
Co(II) is accompanied by a loss of absorbance in the 500-550nm region and emergence of a 
feature at 475nm23. Though 412nm is significantly blue-shifted from this characterized state, this 
sample was frozen for EPR spectroscopic analysis to determine if it was in the Co(II) oxidation 
state. No EPR signal was detected, possibly due to insufficient concentration or an EPR-silent 
oxidation state (Co(III)). Though the FL-HgcA sample could not be definitively characterized, 
this simple experiment deconvoluted the spectrum observed in Figure 3.9 into two distinct 
species: aquacobalamin and some corrinoid coordination environment associated with FL-HgcA.  
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Figure 3.10 Deconvolution of Cbl species contributing to purified FL-HgcA spectrum. The 
centrifugal concentrator flow-through spectrum exhibits a maximum at 358nm and feature 
containing peaks ~515nm and 540nm. The FL-HgcA spectrum is characterized by a broad peak 
with a maximum at 410nm. 
3.4 Discussion 
3.4.1 HgcA-1-166 constructs do not bind “base-off” cobalamin 
 Parks et.al. reported the purification and cobalamin reconstitution of HgcA-1-166 and a 
variant in which Cys73, the residue predicted by homology modelling to coordinate the alpha 
axial position of the corrinoid cofactor, is mutated to a threonine (C93T)7. The UV-visible 
analysis of these constructs following stoichiometric addition of aqua-Cbl indicated shifts in the 
UV-visible spectrum, but the nature of these transitions was unclear. Dr. Stephen Tomanicek and 
Dr. Alexander Johs provided us with samples prepared in a similar manner for EPR analysis to 
better understand the Cbl coordination environment in these samples. The EPR spectra obtained 
in section 3.3.1 overlay with that of cob(II)alamin and the nitrogen superhyperfine triplet 
splitting observed indicates the “base-on” configuration. This suggests that Cbl associated with 
these samples is not coordinated to the HgcA-1-166 in a “base-off, Cys-on” mode. This clarifies 
the shifts observed in the UV-visible spectra as indicative of cobalamin association with the 
purified HgcA constructs or reduction by exposed Cys residues, but not cofactor incorporation 
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into HgcA in the hypothesized “base-off” mode. Furthermore, the MBP-HgcA-1-166 construct, 
which was more highly expressed and readily soluble, also was not reconstituted by addition of 
Cbl to purified protein.  
3.4.2 Screen of HgcA truncated constructs 
 Truncation of proteins at the N- and C-termini27 and/or removal of regions with predicted 
disorder28 are common structural biology approaches to generate protein constructs suitable for 
large-scale expression and purification. The design of such constructs ranges from semi-rational 
to random screening, as the effect of seemingly minor alterations can dramatically impact protein 
solubility and stability. Here we identify that HgcA constructs lacking the C-terminal 
transmembrane domain are more readily soluble after truncation of 30+ residues of the N-
terminus (Figure 3.6). The region of HgcA which exhibits high sequence similarity to the CFeSP 
is composed of residues 43-166 – the N-terminal 42 residues are highly positively charged and 
no function for this region has been proposed. However, these constructs are not reconstituted by 
in vitro addition of Cbl, in a similar result to the HgcA-1-166 construct. It has been observed by 
in vivo mutagenesis studies that genomic deletion of the HgcA transmembrane domain 
eliminates the host organism’s capacity to synthesize MeHg9. Taken together, the in vivo data are 
consistent with the observations in this work that the N-terminal cytosolic domain is not 
competent to bind Cbl. However, the mechanism of Cbl incorporation into HgcA in vivo is not 
known – many examples of corrinoid proteins exist within the scientific literature which cannot 
be purified as soluble proteins from heterologous systems and reconstituted by simple addition of 
Cbl17,29. It may be that HgcA must encounter Cbl co-translationally or in the presence of a 
chaperone to incorporate “base-off” Cbl, regardless of the presence of the C-terminal 
transmembrane domain. 
3.4.3 FL-HgcA and HgcA-1-175 exhibit different cobalamin spectra after co-expression 
with pBAD-BtuCDEFB 
 The acquisition of the pBAD42-BtuCEDFB co-expression system made it possible to test 
the hypothesis that the HgcA TM domain is required to bind Cbl. FL-HgcA and HgcA-1-175 
were purified in the presence of the resulting exaggerated levels of intracellular cobalamin (See 
Figure 3.11). Both constructs were purified under the same conditions by Ni-NTA affinity 
chromatography and analyzed by UV-visible spectroscopy. The HgcA-1-175 truncated construct 
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displayed low intensity spectral features suggestive of aquaCbl in its UV-visible spectrum, 
whereas the purified FL-HgcA indicated a higher concentration of Cbl co-purified with the 
protein. In light of (a) these results, (b) the suggestion from HgcA in vitro reconstitution 
discussed in sections 3.4.1 and 3.4.2, and (c) the in vivo defect in MeHg biosynthesis after 
deletion of the HgcA TM domain observed by Smith et.al.9, we conclude that neither addition of 
cobalamin to purified HgcA nor an increase in intracellular Cbl during expression result in 
purification of holo-HgcA because the HgcA transmembrane domain is structurally or 
conformationally required for cofactor binding. 
3.4.4 UV-visible spectral features of FL-HgcA 
 After larger-scale purification of FL-HgcA and buffer exchange, the FL-HgcA spectrum 
in Figure 3.9 was deconvoluted into two components. One, with wavelength maxima at 358nm 
and 515nm/540nm, corresponds to an an oxidized cob(III)alamin, in which a high intensity peak 
near ~350nm and a lower intensity feature in the 500nm-550nm range are observed26. The other 
exhibits a single broad feature ~410nm and is not readily assigned to published spectra – the 
presence of the reductant BME in purification buffers may be sufficient to reduce the cobalamin 
to Co(II), but Co(II) corrinoid spectra are typically characterized by a feature at 475nm23. We are 
currently working to optimize the purification and detergent extraction of FL-HgcA to yield 
greater amounts of protein toward assigning this coordination environment. 
3.4.5 Conclusions 
 Here we present a variety of attempts to heterologously express and purify HgcA. EPR 
analysis of HgcA-1-166 indicated that reported spectral shifts upon cofactor addition were not 
indicative of “base-off” incorporation into the protein. A panel of HgcA truncations was 
designed and constructs which exhibited robust heterologous expression and solubility after cell 
lysis were identified. These constructs were similarly unable to be reconstituted with Cbl in vitro. 
Heterologous expression of HgcA-1-175 was compared side-by-side with the full length HgcA 
protein in the presence of high intracellular Cbl, promoted by co-expression with an inducible 
copy of the btu genes. The truncated variant failed to co-purify with Cbl to the same level as the 
FL-HgcA, leading us to the conclusion that the C-terminal TM domain may be structurally or 
functionally required for Cbl binding to HgcA. The FL-HgcA exhibits an unusual UV-visible 
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spectrum which we hope will lend itself to further characterization and yield insight into the Cbl 
binding mode of HgcA.  
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Chapter 4 Conclusions and Future Directions 
4.1 Conclusions  
 Both HgcA and HgcB contain metal cofactors which present challenges to heterologous 
production. As these proteins are expressed at low levels in two well-characterized model Hg 
methylating organisms, Desulfovibrio desulfuricans ND1321and Geobacter sufurreducens PCA2, 
large-scale purification from these hosts appears a difficult and unattractive method. Here we 
present protocols for co-expression of these genes in Escherichia coli K12 derived strains with 
plasmid-encoded cofactor uptake and/or incorporation systems, developed by the Takahashi3 and 
Booker4 laboratories, respectively. While the maltose binding protein (MBP) affinity tag 
solubilizes the expressed HgcB and allows for facile affinity purification, our inability to remove 
the MBP tag from HgcB after proteolysis is a limitation of this method – this could be 
investigated by purification optimization or a different affinity tag could be used. Further 
optimization of HgcA purification could include its assembly into nanodiscs to better mimic its 
native transmembrane conformation5. Perhaps co-expression of HgcA and HgcB yields a stable 
protein complex and would stabilize/solubilize HgcB in the absence of the MBP tag; these 
efforts are ongoing in our laboratory. Nonetheless, these are the first successful protocols for 
expression and purification of HgcA and HgcB to our knowledge, and the ability to produce 
large quantities of these proteins will be critical to future in vitro characterization.  
 In Chapter 2, we show that heterologously expressed MBP-HgcB (abbreviated MHB) 
exhibits UV-visible characteristics typical of [4Fe-4S] cluster ferredoxins. Its UV-visible 
spectrum is redox-dependent and can be quenched by chemical reduction. The EPR spectrum of 
MHB revealed the feature centered at g = 1.94 indicative of [4Fe-4S] clusters. It is noteworthy 
that titanium (III) citrate was required to reduce MHB to the EPR-active +1 state, whereas 
dithionite reduced MHB did not exhibit an EPR spectrum, suggesting that the MHB [4Fe-4S] 
cluster potentials are quite low; this deserves further study as it could inform the in vivo ability of 
HgcB to transfer electrons to a low-potential (~500mV) corrinoid. Furthermore, UV-visible and 
EPR spectroscopic studies of a panel of Cys mutants of HgcB exhibit identical characteristics to 
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the wild-type construct, suggesting that their overall conformation is not adversely affected by 
Ser substitution of Cys73 and/or Ala substitution of Cys94 and Cys95.  
 A Hg(TNB)2 titration
6 was used to probe the Hg(II) binding characteristics of MHB. 
Stopped-flow rapid kinetic experiments of the Hg(TNB)2 interaction with MHB and a panel of 
variants in which combinations of the conserved Cys 73, Cys94, and/or Cys95 residues were 
substituted with Ala or Ser by site-directed mutagenesis. The data obtained indicated differential 
rates of Hg(TNB)2 decay and TNB
- appearance between various sets of mutants. Briefly, the 
SCC variant was found to fit to the simplest model of Hg(II) binding in a single phase – this was 
taken as an indication that the Cys94/Cys95 pair bind stoichiometric Hg in the first step of the 
MHB:Hg interaction. Curiously, this was not consistent with the wild-type CCC variant, which 
exhibited a phase with a similar rate of Hg(TNB)2 decay to the SCC (~100s
-1), but an additional 
phase was also observed in the fit to a double exponential model. This rate, also observed in the 
CAC and CCA mutants, we attribute to bidentate coordination of Hg(II) by HgcB, which appears 
to require two of the three relevant Cys residues. The slightly slower, though still rapid, decay of 
Hg(TNB)2 induced by CAA and SAA, which contain only Cys73 and no Cys residues, 
respectively, we attribute to nonspecific displacement of the iron-sulfur clusters by Hg(II) 
binding to the Cys residues involved in their coordination. These data provide insight into the 
hypothesis that these Cys residues comprise a Hg(II) binding site and deliver the Hg(II) substrate 
to the HgcA corrinoid for methylation, and are consistent with the observed in vivo requirement 
for Cys 73 and either Cys94 or Cys95 for Hg methylating activity7.  
 FL-HgcA was purified in Chapter 3. As a series of HgcA constructs lacking the C-
terminal transmembrane region could not be reconstituted in vitro with Cbl cofactor, a co-
expression system was used to increase the intracellular level of Cbl for incorporation into HgcA 
during expression. When compared to a truncated HgcA-1-175 construct expressed in a similar 
manner, the truncated variant did not co-purify with a significant amount of Cbl incorporation – 
we suggest that this indicates the full-length protein is structurally required for cofactor binding, 
though it may or may not directly interact with the bound Cbl. The FL-HgcA UV-visible 
spectrum exhibited an unusual and broad feature centered at ~412nm which could not be 
correlated to a known Cbl spectrum. No EPR signal was detected in the as-purified, aerobic 
protein, but this heterologous expression and detergent extraction can hopefully be optimized to 
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generate a robust production method for subsequent studies of HgcA bound to “base-off” 
corrinoid cofactor.  
4.2 Future Directions 
 The work presented in this dissertation represents a scratch in the surface of our 
understanding of hgcAB-mediated Hg methylation. Though in vivo studies have strongly 
indicated the direct involvement of HgcA and HgcB in the Hg methylation reaction7,8, an in vitro 
assay showing this functionality would definitively show that HgcA and HgcB comprise the 
minimal components necessary for MeHg biosynthesis. Such a functional assay would 
necessitate the generation of MeHg, which is highly toxic and dangerously volatile. Additionally, 
it is unknown whether an equilibrium HgcAB reaction could utilize MeHg+ as a substrate and 
generate dimethylmercury, which exhibits even greater toxicity and membrane permeability. Our 
collaborators at Oak Ridge National Laboratory routinely generate and quantify these Hg species 
using established and safe methods, so, though care must be taken, this functional assay is within 
reach now that methods for HgcA and HgcB expression have been established.  
A further hypothesis concerning the in vitro stability and solubility of HgcA and HgcB is 
that the two proteins form a complex in vivo – this is based on the fact that they appear “side-by-
side” in genomes in which they are found, are not found encoded without the other, and, in a few 
examples, are found as a single fusion gene9. We also observe charge complementarity, 
indicating potential for electrostatic interaction, between the theoretical isoelectric points (pI) of 
the HgcA and HgcB constructs we study from Desulfovibrio desulfuricans ND132: the soluble 
region of HgcA has a theoretical pI of 10.0 whereas that of HgcB is 6.7. Pull-down assays in 
which an affinity tag is encoded at the terminus of HgcA or HgcB have been attempted by our 
collaborators, but hampered by the low level of HgcAB expression in native organisms. 
Heterologous co-expression of these genes could indicate whether they co-purify or improve the 
in vitro solubility of either protein – though no results are presented in this work, we have also 
constructed plasmids to test the effect of this co-expression on the solubility of HgcA and HgcB 
which we hope will provide insight into the HgcA:HgcB interaction. A structural model of HgcA 
and HgcB, derived from protein homology and structure prediction, has been computationally 
developed by our collaborators and provides a starting point for mutagenesis studies which could 
probe specific predicted interactions at the HgcA:HgcB interface.  
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 The “base-off, Cys-on” HgcA corrinoid coordination environment is hypothesized to 
allow catalysis at the Co center which has not been seen in a biological system, namely the 
transfer of a methyl anion species10. Spectroscopic determination of the HgcA corrinoid 
coordination environment will provide insight into the chemical mechanism and inform the 
nature of Co-C bond dissociation. Specifically, the Co oxidation state following single-turnover 
methyl transfer to Hg(II) could be easily identified by EPR and would provide insight into the 
mechanism of methyl transfer. Of course, structural information concerning the corrinoid 
binding site, derived from X-ray crystallographic or extended X-ray absorption fine structure 
(EXAFS) data would be extremely valuable to mechanistic study.  
 More broadly, the biological functions of HgcA and HgcB are yet unknown: is there an 
as-yet unidentified benefit that MeHg production confers a host microorganism? Or do these 
genes play a primary role in carbon metabolism and adventitiously convert Hg(II) to MeHg? 
Proteomic studies have identified some differential expression in hgcAB deletion mutants, but 
this has yet to be investigated further1,2. Bioinformatic insight into these differentially expressed 
pathways could perhaps yield candidates for in vivo mutagenesis to determine partners of HgcA 
and HgcB critical to Hg methylation. We hope that (1) an understanding of the mechanism of 
this reaction and its catalytic efficiency and (2) the identification of other pathway components 
(electron donor, methyl donor, uptake and export processes, etc.) will provide answers to these 
overarching questions about the role of HgcA and HgcB in their microbial hosts.  
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